WO2024070898A1 - Blood vessel piercing device and blood vessel piercing system - Google Patents
Blood vessel piercing device and blood vessel piercing system Download PDFInfo
- Publication number
- WO2024070898A1 WO2024070898A1 PCT/JP2023/034346 JP2023034346W WO2024070898A1 WO 2024070898 A1 WO2024070898 A1 WO 2024070898A1 JP 2023034346 W JP2023034346 W JP 2023034346W WO 2024070898 A1 WO2024070898 A1 WO 2024070898A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- light
- puncture device
- light source
- blood
- blood vessel
- Prior art date
Links
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 162
- 230000017531 blood circulation Effects 0.000 claims abstract description 138
- 230000000903 blocking effect Effects 0.000 claims abstract description 117
- 239000008280 blood Substances 0.000 claims abstract description 81
- 210000004369 blood Anatomy 0.000 claims abstract description 81
- 230000003287 optical effect Effects 0.000 claims abstract description 20
- 230000002792 vascular Effects 0.000 claims description 59
- 230000005540 biological transmission Effects 0.000 claims description 20
- 230000002093 peripheral effect Effects 0.000 claims description 20
- 230000001629 suppression Effects 0.000 claims description 12
- 230000004087 circulation Effects 0.000 abstract 1
- 238000012790 confirmation Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 description 20
- 238000003780 insertion Methods 0.000 description 11
- 230000037431 insertion Effects 0.000 description 11
- 238000010586 diagram Methods 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 238000012986 modification Methods 0.000 description 9
- 230000004048 modification Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000013307 optical fiber Substances 0.000 description 5
- -1 polytetrafluoroethylene Polymers 0.000 description 5
- 238000012800 visualization Methods 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 239000000113 methacrylic resin Substances 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 230000002238 attenuated effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- 229920000106 Liquid crystal polymer Polymers 0.000 description 2
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000006229 carbon black Substances 0.000 description 2
- 210000000078 claw Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000010422 painting Methods 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920005672 polyolefin resin Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229910000838 Al alloy Inorganic materials 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920001774 Perfluoroether Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920001230 polyarylate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
Definitions
- the present invention relates to a vascular puncture device and a vascular puncture system.
- WO 2022/176880 discloses a blood vessel puncture device equipped with a linear portion (needle body and catheter shaft) capable of puncturing a blood vessel in a living body.
- the blood vessel puncture device includes a needle hub provided at the base end of the needle body, and a light source unit detachably provided at the base end of the needle hub. With the light source unit attached to the base end of the needle hub, the base end of the needle body is connected to the light source unit.
- An obstruction member that prevents blood from flowing into the light source unit is provided in the inner cavity of the needle body. Light emitted by the light source portion of the light source unit passes through the obstruction member and is guided out from the tip opening of the needle body.
- the light emitted from the tip opening of the needle body is absorbed or attenuated by the blood, so the intensity of the light received or visible outside the body part changes before and after the needle body secures the blood vessel. Therefore, it is possible to easily and quickly know whether the needle body has secured the blood vessel based on the light emitted by the light source unit.
- the light source unit when inserting a linear portion into a thick blood vessel or a blood vessel close to the skin, it may be possible to easily determine whether the blood vessel has been secured in the linear portion without relying on the light emitted by the light source unit. If the light source unit is detachable from the needle hub as in the above-mentioned International Publication No. 2022/176880, it is convenient to be able to select whether or not to use the light source unit depending on the situation. In addition, the light source unit, which is relatively expensive, can be reused, reducing the cost of the device for performing the blood vessel puncture procedure.
- the inner cavity of the needle body is blocked by a blocking member.
- the needle hub does not have a blood inlet portion (blood inlet portion for checking flashback) for confirming that the needle body has secured a blood vessel.
- blood inlet portion for checking flashback there is a problem that blood flowing into the blood inlet portion may come into contact with the light source unit, and the light source unit that has come into contact with blood cannot be reused.
- the present invention aims to solve the above-mentioned problems.
- One aspect of the present invention is a blood vessel puncture device having a linear part capable of puncturing a blood vessel at a living body part, the linear part including a tubular needle body, and a needle hub provided at the base end of the needle body, the blood vessel puncture device comprising a blood flow blocking part provided at the base end of the needle hub, a light source unit having a light source part that emits light and is detachable to an attachment part of the blood flow blocking part, and an optical path that guides the light emitted by the light source part to the tip end of the linear part, the light emitted by the light source part is guided to the outside from the tip end of the linear part, at least one of the needle hub and the blood flow blocking part is provided with a blood inflow part for checking flashback, through which blood flowing in from the tip opening of the needle body is guided, and the blood flow blocking part is formed so as to prevent the blood from flowing to the attachment part.
- the light source portion may emit the light toward the tip of the linear portion.
- the light source unit may have a housing that houses the light source section, and the housing may have a connection section that is detachable from the attachment section.
- the blood flow blocking portion may be fixed to the base end of the needle hub.
- the blood flow blocking portion may be detachable from the base end of the needle hub.
- the light emitted by the light source unit may be guided out from the tip opening of the needle body through the inner cavity of the needle body.
- the inner surface of the needle body may be provided with a reflecting portion that reflects the light emitted by the light source unit.
- the optical path may include a light-guiding member for guiding the light emitted by the light source unit to the tip of the needle body.
- the tip of the light-guiding member may be positioned at the tip of the needle body when inserted into the inner cavity of the needle body.
- the base end of the light-guiding member may be supported by the blood flow blocking portion.
- the blood flow blocking section is detachable from the base end of the needle hub, and the inner surface of the needle hub is provided with a guide surface for guiding the light guiding member into the inner cavity of the needle body when the blood flow blocking section is attached to the base end of the needle hub, and the guide surface may taper in diameter toward the needle body.
- the blood flow blocking section includes a filter that blocks the flow of blood from the blood inlet section to the attachment section, and a support section that supports the filter, and the attachment section may be provided at the base end of the support section.
- the light source unit may emit light that includes near-infrared light.
- a blood vessel puncture device comprising a tubular catheter shaft having a lumen through which the needle body is inserted, and a catheter hub provided at the base end of the catheter shaft and having a lumen through which the needle body is inserted, and the linear portion may include the needle body and the catheter shaft.
- the optical path may be provided in the wall of the blood flow blocking portion, the wall of the needle hub, the wall of the catheter hub, and the wall of the catheter shaft, and the light emitted by the light source may be guided to the outside from the tip of the catheter shaft.
- a light transmission suppression section that suppresses the transmission of the light emitted by the light source section may be provided on the outer peripheral surface of each of the wall section of the blood flow blocking section, the wall section of the needle hub, the wall section of the catheter hub, and the wall section of the catheter shaft.
- the blood flow blocking portion may be movable along the axial direction of the needle body while being liquid-tightly attached to the base end of the needle hub.
- the base end of the needle hub may be provided with a female thread portion
- the tip end of the blood flow blocking portion may be provided with a male thread portion that screws into the female thread portion
- the male threaded portion may be in liquid-tight contact with the female threaded portion.
- Another aspect of the present invention is a blood vessel puncture system comprising a blood vessel puncture device according to any one of items (1) to (19), a light receiving unit that receives the light emitted from the tip of the linear portion, and an image display unit that displays a received light image created based on the light received by the light receiving unit.
- the light source unit is detachable from the attachment part of the blood flow blocking part, it is possible to select whether or not to use the light source unit depending on the situation. Furthermore, when the light source unit is used, the light emitted by the light source unit is guided to the tip of the linear part via the optical path.
- the linear part is in a state before the blood vessel is secured, the light derived from the tip of the linear part passes through the biological tissue (subcutaneous tissue other than the blood vessel, etc.) and is guided to the outside of the biological part.
- the biological tissue subcutaneous tissue other than the blood vessel, etc.
- the light derived from the tip of the linear part is absorbed by the blood or attenuated when passing through the blood. In other words, the intensity of the light received or visible outside the biological part changes before and after the blood vessel is secured by the linear part, so it is possible to easily and quickly know whether the blood vessel is secured by the linear part based on the light emitted by the light source part.
- the user can accurately tell whether the needle body has secured a blood vessel by visually checking the blood flow into the blood inlet section. At this time, the blood flow to the attachment section is blocked by the blood flow blocking section. Therefore, the light source unit attached to the attachment section does not come into contact with blood. Therefore, the light source unit can be reused.
- FIG. 1 is a schematic diagram of a blood vessel puncture system according to one embodiment of the present invention.
- 2 is an exploded perspective view of the vascular puncture device of FIG. 1.
- FIG. 3 is a longitudinal cross-sectional view of the vascular puncture device of FIG.
- FIG. 4 is a first explanatory diagram of a procedure for puncturing a blood vessel using the blood vessel puncture device of FIG.
- FIG. 5 is a second explanatory diagram of the puncture procedure.
- FIG. 6 is an explanatory diagram showing a received light image in the state shown in FIG.
- FIG. 7 is a third explanatory diagram of the puncture procedure.
- FIG. 8 is an explanatory diagram showing a received light image in the state shown in FIG. FIG.
- FIG. 9 is a fourth explanatory diagram of the puncture procedure.
- FIG. 10 is a fifth explanatory diagram of the puncture procedure.
- Fig. 11A is a partially omitted longitudinal sectional view of a blood vessel puncture device including a light source unit according to a first configuration example
- Fig. 11B is an explanatory diagram of a state in which the light source unit shown in Fig. 11A is attached to a mounting portion.
- FIG. 12 is a longitudinal sectional view, with a portion thereof omitted, of a blood vessel puncture device including a light source unit according to the second configuration example.
- FIG. 13 is a longitudinal sectional view of a blood vessel puncture device according to a first modified example.
- FIG. 14A is a first explanatory view of a procedure for using the vascular puncture device of Figure 13.
- Figure 14B is a second explanatory view of the procedure for using the device.
- 15A and 15B are third and fourth explanatory views of the usage procedure.
- FIG. 16 is a longitudinal sectional view of a blood vessel puncture device according to a second modified example.
- FIG. 17 is an explanatory diagram showing a received light image of the blood vessel puncture device of FIG. 16 in a state before the blood vessel is secured.
- FIG. 18 is a cross-sectional view illustrating a blood flow blocking portion according to an example of the configuration.
- FIG. 19 is a longitudinal sectional view of a blood vessel puncture device according to a third modified example.
- FIG. 20 is a longitudinal sectional view of a blood vessel puncture device according to a fourth modified example.
- FIG. 21 is a longitudinal sectional view of a blood vessel puncture device according to a fifth modified example.
- a vascular puncture system 10 includes a vascular puncture device 12 and a visualization device 14.
- the vascular puncture device 12 is configured as an indwelling needle (peripheral arterial and venous indwelling needle, dialysis indwelling needle, etc.) for administering an infusion (medicinal solution) into a blood vessel 302 of a living body part 300 (see FIG. 7).
- the vascular puncture device 12 may also be a vascular access product such as a peripherally inserted central venous catheter (PICC), a midline catheter, or a central venous catheter.
- PICC peripherally inserted central venous catheter
- the vascular puncture device 12 may also be a blood collection needle without a catheter.
- the vascular puncture device 12 comprises a catheter member 16, a needle member 18, a blood flow blocking portion 20, and a light source unit 22.
- the catheter member 16, the needle member 18, and the blood flow blocking portion 20 are disposable items that are discarded after a single use.
- the light source unit 22 is a reusable item that can be used multiple times.
- the vascular puncture device 12 In its initial state, the vascular puncture device 12 has a linear portion 24 capable of puncturing a blood vessel 302 in a biological site 300.
- the linear portion 24 is formed by inserting the tubular needle body 38 of the needle member 18 into the lumen 32 of the tubular catheter shaft 28 of the catheter member 16.
- the linear portion 24 has a double tube structure.
- the vascular puncture device 12 has an optical path 26 that guides light L1 emitted by the light source portion 66 of the light source unit 22 located at the base end of the vascular puncture device 12 to the tip of the linear portion 24.
- the catheter member 16 has a flexible catheter shaft 28 and a catheter hub 30 provided at the base end of the catheter shaft 28.
- the catheter shaft 28 is a tubular member that can be continuously inserted into a blood vessel 302 of a biological site 300.
- the catheter shaft 28 has an inner lumen 32 (medicinal solution supply path) that extends axially over its entire length.
- a tip opening 34 that communicates with the inner lumen 32 is formed at the tip of the catheter shaft 28.
- Examples of materials that can be used to make the catheter shaft 28 include fluororesins such as polytetrafluoroethylene (PTFE), ethylene-tetrafluoroethylene copolymer (ETFE), and perfluoroalkoxy fluororesin (PFA), olefin resins such as polyethylene and polypropylene, or mixtures of these, polyurethane, polyester, polyamide, polyether nylon resin, and mixtures of olefin resins and ethylene-vinyl acetate copolymers.
- fluororesins such as polytetrafluoroethylene (PTFE), ethylene-tetrafluoroethylene copolymer (ETFE), and perfluoroalkoxy fluororesin (PFA)
- olefin resins such as polyethylene and polypropylene, or mixtures of these, polyurethane, polyester, polyamide, polyether nylon resin, and mixtures of olefin resins and ethylene-vinyl acetate copolymers.
- the wall of the catheter shaft 28 forms part of the light path 26.
- the wall of the catheter shaft 28 guides the light L1 emitted by the light source unit 66 from the base end of the catheter shaft 28 to the tip end 35.
- At least the part of the catheter shaft 28 that forms the light path 26 is transparent so that the light L1 emitted by the light source unit 66 can pass through.
- the catheter shaft 28 may be entirely transparent.
- the material constituting at least the portion of the catheter shaft 28 that forms the optical path 26 may include, for example, methacrylic resin.
- the portion of the catheter shaft 28 that forms the optical path 26 may be hollow.
- the catheter hub 30 is formed in a hollow (cylindrical) shape.
- the base end of the catheter shaft 28 is fixed to the tip of the catheter hub 30.
- the catheter hub 30 is preferably made of a material harder than the catheter shaft 28.
- the material of the catheter hub 30 is not particularly limited, but examples of suitable materials that can be used include thermoplastic resins such as polypropylene, polycarbonate, polyamide, polysulfone, polyarylate, methacrylate-butylene-styrene copolymer, polyurethane, acrylic resin, and ABS resin.
- a hemostatic valve (not shown) is provided in the inner cavity 36 of the catheter hub 30.
- the wall of the catheter hub 30 forms part of the light path 26.
- the wall of the catheter hub 30 guides the light L1 emitted by the light source unit 66 from the base end to the tip end of the catheter hub 30.
- At least the portion of the catheter hub 30 that forms the light path 26 is transparent so that the light L1 emitted by the light source unit 66 can pass through.
- the entire catheter hub 30 may be transparent.
- the material constituting at least the portion of the catheter hub 30 that forms the optical path 26 may include, for example, methacrylic resin.
- the portion of the catheter hub 30 that forms the optical path 26 may be hollow.
- a light-guiding member e.g., optical fiber, acrylic member, glass member, light-emitting tube, etc.
- the light-guiding member may be provided continuously from the base end to the tip end of the catheter hub 30, or may be provided intermittently.
- the needle member 18 comprises a needle body 38 and a needle hub 40 provided at the base end of the needle body 38.
- the needle body 38 is a tubular member having sufficient rigidity to puncture a biological site 300 (see FIGS. 5 and 7).
- the needle body 38 is formed in a cylindrical shape.
- the needle body 38 has an inner cavity 42 extending along the axial direction. The needle body 38 is inserted into the inner cavity 32 of the catheter shaft 28 and the inner cavity 36 of the catheter hub 30 in the initial state (assembled state) of the vascular puncture device 12.
- the needle body 38 is made of a metal material such as stainless steel, aluminum, an aluminum alloy, titanium, or a titanium alloy.
- the needle body 38 may also be made of a resin material such as polypropylene (PP), polycarbonate (PC), polyether ether ketone (PEEK), or liquid crystal polymer (LCP).
- PP polypropylene
- PC polycarbonate
- PEEK polyether ether ketone
- LCP liquid crystal polymer
- a blade surface 44 is formed at the tip of the needle body 38, which is inclined relative to the axis of the needle body 38.
- a tip opening 46 that communicates with the inner cavity 42 of the needle body 38 is formed on the blade surface 44.
- the needle hub 40 is formed to be hollow (cylindrical).
- the tip of the needle hub 40 is provided with a needle connection hole 48 into which the base end of the needle 38 is inserted.
- the base end of the needle hub 40 is provided with a first engagement portion 50.
- the first engagement portion 50 is a recess (hole) that opens into the base end surface of the needle hub 40.
- the needle hub 40 has an inner cavity 52 that communicates with the inner cavity 42 of the needle body 38. Blood that has flowed through the inner cavity 42 of the needle body 38 flows into the inner cavity 52 of the needle hub 40.
- the needle hub 40 can be made of the same materials as those of the catheter hub 30 described above.
- the wall of the needle hub 40 forms part of the light path 26.
- the wall of the needle hub 40 guides the light L1 emitted by the light source unit 66 from the base end to the tip end of the needle hub 40.
- At least the part of the needle hub 40 that forms the light path 26 is transparent so that the light L1 emitted by the light source unit 66 can pass through.
- the entire needle hub 40 may be transparent.
- the material of at least the portion of the needle hub 40 that forms the light path 26 may include, for example, methacrylic resin.
- the portion of the needle hub 40 that forms the light path 26 may be hollow.
- a light-guiding member e.g., optical fiber, acrylic member, glass member, light-emitting tube, etc.
- the light-guiding member may be provided continuously from the base end to the tip end of the needle hub 40, or may be provided intermittently.
- the blood flow blocking section 20 has a support section 54 and a filter 56 supported by the support section 54.
- the support section 54 is formed hollow.
- the support section 54 supports the filter 56 arranged inside the support section 54.
- a second engagement section 58 that engages with the first engagement section 50 is provided at the tip of the support section 54.
- the second engagement section 58 is a convex section that fits into the first engagement section 50, which is a concave section.
- the first engagement section 50 may be a convex section and the second engagement section 58 may be a concave section.
- the support section 54 is fixed to the needle hub 40.
- the support section 54 may be molded integrally with the needle hub 40.
- the support portion 54 has a blood flow path 60 that communicates with the inner cavity 52 of the needle hub 40. Blood in the inner cavity 52 of the needle hub 40 flows through the blood flow path 60.
- the inner cavity 52 of the needle hub 40 and the blood flow path 60 form a blood inlet portion 62 for checking flashback, into which blood that has flowed in from the tip opening 46 of the needle body 38 is guided.
- the blood flow path 60 extends along the axial direction of the needle body 38.
- the blood flow path 60 is located on an extension of the axis of the needle body 38.
- a mounting portion 64 for mounting the light source unit 22 is provided on the support portion 54 in the proximal direction from the filter 56.
- the mounting portion 64 is a recess (hole) that opens into the proximal end surface of the support portion 54.
- the mounting portion 64 is located on the axis of the needle body 38.
- the wall of the support portion 54 forms part of the light path 26.
- the wall of the support portion 54 guides the light L1 emitted by the light source portion 66 from the base end to the tip end of the support portion 54.
- At least the portion of the support portion 54 that forms the light path 26 is transparent so that the light L1 emitted by the light source portion 66 can pass through.
- the entire support portion 54 may be transparent.
- the constituent material of at least the portion of the support 54 that forms the light path 26 may include, for example, methacrylic resin.
- the portion of the support 54 that forms the light path 26 may be hollow.
- a light-guiding member e.g., optical fiber, acrylic member, glass member, light-emitting tube, etc.
- the light-guiding member may be provided continuously from the base end to the tip end of the support 54, or may be provided intermittently.
- the filter 56 is positioned so as to block the blood flow path 60 from the proximal direction.
- the filter 56 allows air to flow while blocking blood flow.
- the filter 56 blocks blood flowing through the blood flow path 60 from flowing into the attachment part 64.
- the filter 56 is preferably made of a material that transmits the light L1 emitted by the light source part 66.
- One or more air vent holes are formed in the support section 54 proximal to the filter 56 to allow blood to flow smoothly into the blood inlet section 62.
- one or more air vent holes for discharging air from within the blood inlet section 62 to the outside may be provided in the needle hub 40.
- a filter 56 is provided in the air vent hole to prevent blood from flowing out.
- the light source unit 22 is formed so as to be detachable from the mounting portion 64.
- the outer surface of the light source unit 22 is flush with the outer surface of the blood flow blocking portion 20.
- the outer surface of the light source unit 22 does not have a protrusion that protrudes outward beyond the outer surface of the blood flow blocking portion 20 when the light source unit 22 is mounted on the mounting portion 64.
- the outer surface of the light source unit 22 may be located radially inward (inner) than the outer surface of the blood flow blocking portion 20.
- the light source unit 22 has a light source section 66, a power supply section 68, and a housing 70.
- the light source section 66 is housed in the housing 70.
- an LED for example, an LED, a lamp (e.g., a halogen lamp), a laser irradiation unit (e.g., a laser diode), etc. can be used.
- the light source unit 66 emits light L1 in a wavelength range that is easily absorbed by hemoglobin in blood and easily transmits through subcutaneous tissue. Specifically, the light source unit 66 emits at least one of visible light and near-infrared light.
- the wavelength of visible light is preferably 600 nm or more and less than 700 nm.
- the wavelength of near-infrared light is 700 nm or more and 2500 nm or less, preferably 700 nm or more and 1400 nm or less, and more preferably 780 nm or more and 940 nm or less.
- the light L1 emitted by the light source unit 66 has a peak wavelength of 600 nm or more and 2500 nm or less.
- the light source unit 66 may simultaneously emit light L1 of multiple wavelengths. That is, the light source unit 66 may simultaneously emit, for example, visible light of 600 nm and near-infrared light of 850 nm.
- the light source unit 66 is capable of adjusting the brightness of the light L1.
- the light source unit 66 may be lit continuously or may flash.
- the power supply unit 68 is provided in the housing 70.
- the power supply unit 68 supplies power to the light source unit 66.
- the power supply unit 68 includes, for example, a battery. Examples of the battery include a primary battery, a secondary battery, a solar cell, etc.
- the power supply unit 68 may include a wireless power supply device, or may include a plug that can be connected to a wiring socket connector (outlet).
- the power supply unit 68 is provided at the base end of the housing 70.
- the power supply unit 68 may be housed within the housing 70.
- the housing 70 is formed, for example, in a tubular (e.g., cylindrical) shape.
- the housing 70 has a housing main body 74 in which an accommodating space 72 for the light source unit 66 is formed, and a connecting portion 76 that protrudes from the housing main body 74 and is detachable from the mounting portion 64.
- a portion of the housing main body 74 is formed from a material that is opaque to the light L1.
- a portion of the housing main body 74 (the outer peripheral surface or the inner peripheral surface) is coated with a material that is opaque to the light L1.
- connection part 76 is a convex part that can be fitted into the mounting part 64, which is a concave part.
- a light guide hole 78 that communicates with the storage space 72 is formed in the connection part 76.
- the light guide hole 78 opens at the tip surface of the connection part 76.
- the connection part 76 may be formed solid. In this case, the connection part 76 has transparency so that the light L1 emitted by the light source part 66 can pass through.
- connection part 76 and the attachment part 64 preferably have smooth surfaces without any irregularities so that they can be easily wiped with alcohol.
- the light source part 66 is located on an extension of the axis of the needle body 38.
- the connection part 76 is attached to the attachment part 64, the light source part 66 emits light L1 toward the tip of the needle body 38.
- the mounting structure of the blood flow blocking portion 20 and the light source unit 22 may be such that the mounting portion 64 is a convex portion and the connection portion 76 is a concave portion (hole portion).
- the mounting structure is not limited to a fitting structure using convex and concave portions, but may be a claw engagement structure, a magnetic attraction structure, a hook-and-loop fastener engagement structure, a screw-threaded structure, etc.
- the vascular puncture device 12 has a light transmission suppression section 80 for suppressing leakage of light L1 emitted by the light source section 66 to the outside when the light L1 is guided to the tip section 35 of the catheter shaft 28.
- the light transmission suppression section 80 is provided on the outer surface of each of the catheter shaft 28, the catheter hub 30, the needle hub 40, and the blood flow blocking section 20.
- the light transmission suppression section 80 is provided from a position shifted from the tip of the catheter shaft 28 in the proximal direction by a predetermined length to the tip of the catheter hub 30. In other words, the light transmission suppression section 80 is not provided at the tip 35 of the catheter shaft 28. That is, the light L1 emitted by the light source section 66 is guided to the outside from the tip 35 of the catheter shaft 28.
- the tip 35 of the catheter shaft 28 may contain a fluorescent material that emits near-infrared light when irradiated with the light L1 emitted by the light source section 66.
- the tip 35 of the catheter shaft 28 may also contain a phosphorescent material that emits near-infrared light.
- the tip 35 of the catheter shaft 28 may be a film that can convert near-infrared light into visible light. In this case, only the tip 35 can be made to emit light without the catheter hub 30 and the needle hub 40 emitting visible light, making it easier to visually recognize the tip 35.
- the light transmission suppression section 80 is provided, for example, on the outer peripheral surfaces of the catheter hub 30, the needle hub 40, and the support section 54. Note that the needle hub 40 and the support section 54 have portions on their outer surfaces where the light transmission suppression section 80 is not provided, so that the blood inlet section 62 can be seen from the outside.
- the light transmission suppression section 80 is formed, for example, by painting a light-opaque material such as carbon black onto the target surface.
- the light transmission suppression section 80 may also be formed, for example, by evaporating or coating a metal film onto the target surface.
- the visualization device 14 includes an irradiation unit 82, a light receiving unit 84, and an image display unit 86.
- the irradiation unit 82 irradiates light L2 to a biological site 300 (object to be visualized) punctured by the vascular puncture device 12.
- the irradiation unit 82 has an irradiation unit main body 88 that emits light L2.
- the irradiation unit main body 88 emits near-infrared light as light L2.
- the wavelength of the near-infrared light emitted by the irradiation unit main body 88 is 700 nm or more and 2500 nm or less, preferably 700 nm or more and 1400 nm or less, and more preferably 780 nm or more and 940 nm or less.
- the wavelengths of light L1 and light L2 may be the same or different.
- the light receiving unit 84 is disposed on the opposite side of the body part 300 from the irradiation unit 82. In other words, the irradiation unit 82 and the light receiving unit 84 are disposed so as to face each other with the body part 300 in between.
- the light receiving unit 84 is a camera (imaging unit) for receiving the light L1 emitted by the light source unit 66 and the light L2 emitted by the irradiation unit 82.
- a CCD camera for near-infrared light is used as the light receiving unit 84.
- the light receiving unit 84 may also be a film capable of converting near-infrared light into visible light.
- the image display unit 86 displays an image (received light image 90) created based on the light L1 and L2 received by the light receiving unit 84.
- the image display unit 86 may be goggles that can be worn or removed by a person, a fixed display, or a projector.
- the irradiation unit 82 may be arranged on the side of the biological part 300 where the light receiving unit 84 is located. In this case, the light receiving unit 84 receives the light L2 emitted by the irradiation unit 82 that is reflected by the biological part 300 (reflected light). In addition, in the visualization device 14, the irradiation unit 82 may be arranged on both the opposite side of the biological part 300 to the light receiving unit 84 and the side of the biological part 300 where the light receiving unit 84 is located. In this case, both the light L2 emitted by each irradiation unit 82 that is transmitted through the biological part 300 (transmitted light) and the light reflected by the biological part 300 (reflected light) are received by the light receiving unit 84.
- the blade surface 44 faces upward and protrudes from the tip opening 34 of the catheter shaft 28 toward the tip.
- the light source unit 22 is not attached to the blood flow blocking section 20.
- the case where the light source section 66 emits light L1 including near-infrared light will be described.
- the user determines whether the light source unit 22 is necessary based on the patient's blood vessel 302 to be punctured. Specifically, if the user determines that the blood vessel 302 to be punctured is easy to grasp from the outside (easy to determine whether the blood vessel is secured) and the light source unit 22 is unnecessary, the user performs the puncture operation of the linear portion 24 (needle body 38 and catheter shaft 28) into the blood vessel 302 without attaching the light source unit 22 to the blood flow blocking portion 20.
- the user attaches the connection portion 76 of the light source unit 22 to the attachment portion 64 of the blood flow blocking portion 20, as shown in FIG. 4.
- the user sets up the visualization device 14. Specifically, as shown in FIG. 5, the irradiation unit 82 is placed below the biological part 300 (e.g., the forearm of a human body) and the light receiving unit 84 is placed above the biological part 300. Then, the irradiation unit 82 irradiates the biological part 300 with light L2 and the tip of the linear part 24 is inserted into the biological part 300 (at a position closer to the blood vessel 302).
- the biological part 300 e.g., the forearm of a human body
- the light receiving unit 84 is placed above the biological part 300.
- the irradiation unit 82 irradiates the biological part 300 with light L2 and the tip of the linear part 24 is inserted into the biological part 300 (at a position closer to the blood vessel 302).
- the light L2 emitted by the irradiation unit 82 then passes through the biological tissue 304 (e.g., skin tissue and muscle tissue) other than the blood vessels 302 of the biological part 300 while being scattered, and the transmitted light L2 (transmitted light) is received by the light receiving unit 84. At this time, the hemoglobin in the blood flowing through the blood vessels 302 absorbs the light L2. Furthermore, the light L2 does not pass through the needle body 38.
- the biological tissue 304 e.g., skin tissue and muscle tissue
- Light L1 emitted by the light source unit 66 is guided out from the tip 35 of the catheter shaft 28 via the optical path 26 (light guide hole 78, support unit 54, needle hub 40, catheter hub 30, and catheter shaft 28).
- Light L1 guided out from the tip 35 of the catheter shaft 28 passes through the biological tissue 304 (e.g., skin tissue or muscle tissue) of the biological part 300 while being scattered, and the transmitted light L1 (transmitted light) is received by the light receiving unit 84.
- biological tissue 304 e.g., skin tissue or muscle tissue
- a received light image 90 created based on the light L1 and L2 received by the light receiving unit 84 is displayed on the image display unit 86.
- the biological tissue 304, blood vessels 302, and the tip of the linear portion 24 are displayed on the received light image 90.
- the tip 35 of the catheter shaft 28 (the portion from which the light L1 is emitted) is displayed brightest (white), and the biological tissue 304 is displayed darker than the tip 35 of the catheter shaft 28.
- the blood vessel 302 and the needle body 38 are displayed darker than the biological tissue 304. Note that when the needle body 38 is not inserted into the blood vessel 302, the brightness of the needle body 38 is equal to or greater than the brightness of the blood vessel 302. This allows the user to easily and clearly distinguish between the blood vessel 302 and the tip 35 of the catheter shaft 28 in the received light image 90.
- the light L1 emitted by the light source 66 is absorbed by the hemoglobin in the blood.
- the light L1 does not reach the light receiving unit 84, or even if it does reach the light receiving unit 84, its intensity is greatly reduced.
- the appearance of the tip 35 of the catheter shaft 28 changes in the received light image 90 (the tip 35 of the catheter shaft 28 becomes darker).
- the brightness of the tip 35 of the catheter shaft 28 becomes equal to or lower than the brightness of the blood vessel 302.
- the brightness of the needle body 38 is equal to or lower than the brightness of the blood vessel 302. Therefore, the user can easily and quickly know from the received light image 90 that the tip 35 of the catheter shaft 28 has been inserted into the blood vessel 302 (the catheter shaft 28 has secured the blood vessel).
- the user removes the needle member 18 from the catheter member 16 while leaving the tip 35 of the catheter shaft 28 in the blood vessel 302, and administers the medicinal liquid into the blood vessel 302 via the lumen 32 of the catheter shaft 28.
- the light source unit 22 is removed from the blood flow blocking portion 20.
- the light source unit 22 removed from the blood flow blocking portion 20 is reused.
- the used needle member 18 and the blood flow blocking portion 20 fixed to the needle hub 40 are discarded together.
- the light source unit 66 when the light source unit 66 emits only visible light, the user can recognize the light L1 emitted from the tip 35 of the catheter shaft 28 before the catheter shaft 28 secures the blood vessel.
- the catheter shaft 28 secures the blood vessel, the light L1 is absorbed by hemoglobin in the blood, and the user cannot recognize the light L1 emitted from the tip 35 of the catheter shaft 28. Therefore, even when the light source unit 66 emits only visible light, the user can easily and quickly know that the linear portion 24 has secured the blood vessel based on the light L1 emitted by the light source unit 66.
- the light source unit 22 is detachable from the attachment portion 64 of the blood flow blocking portion 20, so it is possible to select whether or not to use the light source unit 22 depending on the situation. Furthermore, when the light source unit 22 is used, the light L1 emitted by the light source portion 66 is guided to the tip portion 35 of the catheter shaft 28 via the optical path 26.
- the light L1 emitted from the tip 35 of the catheter shaft 28 passes through the biological tissue 304 (subcutaneous tissue other than the blood vessel 302, etc.) and is guided to the outside of the biological part 300.
- the biological tissue 304 subcutaneous tissue other than the blood vessel 302, etc.
- the light L1 emitted from the tip 35 of the catheter shaft 28 is absorbed by the blood or attenuated as it passes through the blood.
- the intensity of the light L1 that can be received or seen outside the biological part 300 changes before and after the catheter shaft 28 secures the blood vessel, so that it is possible to easily and quickly know whether the catheter shaft 28 (linear part 24) has secured the blood vessel based on the light L1 emitted by the light source unit 66.
- the user can accurately know whether the needle body 38 has secured the blood vessel by visually checking the blood flow into the blood inlet section 62.
- the blood flow to the attachment section 64 is blocked by the blood flow blocking section 20. Therefore, the light source unit 22 attached to the attachment section 64 does not come into contact with blood. Therefore, the light source unit 22 can be reused.
- the light source portion 66 When the light source unit 22 is attached to the attachment portion 64, the light source portion 66 emits light L1 toward the tip of the linear portion 24.
- the light L1 emitted by the light source unit 66 can be easily guided to the tip of the linear portion 24 (the tip 35 of the catheter shaft 28).
- the light source unit 22 has a housing 70 that houses the light source section 66, and the housing 70 has a connection section 76 that can be attached and detached to the attachment section 64.
- the light source unit 66 can be protected by the housing 70.
- the blood flow blocking section 20 is fixed to the base end of the needle hub 40.
- This configuration can prevent blood from leaking between the needle hub 40 and the blood flow blocking portion 20.
- the blood flow blocking section 20 includes a filter 56 that blocks blood flow from the blood inlet section 62 to the attachment section 64, and a support section 54 that supports the filter 56.
- the attachment section 64 is provided at the base end of the support section 54.
- the filter 56 can effectively suppress the flow of blood from the blood inlet portion 62 to the attachment portion 64.
- the light source unit 66 emits light L1 that includes near-infrared light.
- This configuration effectively changes the appearance of the light L1 emitted by the light source unit 66 and guided out from the tip 35 of the catheter shaft 28 before and after the blood vessel is secured.
- the light path 26 is provided in the wall of the blood flow blocking section 20, the wall of the needle hub 40, the wall of the catheter hub 30, and the wall of the catheter shaft 28.
- the light L1 emitted by the light source 66 is guided to the outside from the tip 35 of the catheter shaft 28.
- the catheter shaft 28 has secured a blood vessel based on the light L1 emitted by the light source unit 66.
- the light L1 emitted by the light source unit 66 can be guided to the tip 35 of the catheter shaft 28.
- a light transmission suppression section 80 that suppresses the transmission of light L1 emitted by the light source section 66 is provided on the outer peripheral surface of each of the walls of the blood flow blocking section 20, the needle hub 40, the catheter hub 30, and the catheter shaft 28.
- the light L1 emitted by the light source unit 66 can be efficiently guided to the tip 35 of the catheter shaft 28.
- the vascular puncture system 10 includes a light receiving unit 84 that receives light L1 emitted from the tip of the linear portion 24, and an image display unit 86 that displays a received light image 90 created based on the light L1 received by the light receiving unit 84.
- the vascular puncture device 12 may have a light source unit 22a shown in Figs. 11A and 11B instead of the light source unit 22 described above.
- the light source unit 22a includes a cover portion 100 provided on the housing main body 74.
- the cover portion 100 protrudes in the distal direction beyond the distal end of the housing 70.
- the cover portion 100 is formed, for example, in a cylindrical shape.
- the cover section 100 is formed so as to prevent the light L1 emitted by the light source section 66 from passing through it.
- the cover section 100 is made of an opaque material so as to prevent the light L1 emitted by the light source section 66 from passing through it.
- the cover section 100 may be made of a transparent material and formed by painting the surface with a light-opaque material such as carbon black.
- the cover section 100 may also be made of a transparent material and formed by evaporating or coating a metal film on the surface.
- the cover section 100 may be integrally molded with the housing main body 74, or may be formed as a separate member from the housing main body 74.
- the cover portion 100 is provided on the housing main body 74 so as to cover from the outside the portion of the support portion 54 that forms the light path 26 when the light source unit 22a is attached to the blood flow blocking portion 20.
- the light transmission suppression portion 80 may not be provided on at least the portion of the light path 26 of the support portion 54 that is covered by the cover portion 100.
- the cover portion 100 may be provided on the housing main body 74 so as to cover from the outside the portion of the needle hub 40 that forms the light path 26 when the light source unit 22a is attached to the blood flow blocking portion 20.
- the vascular puncture device 12 may have a light source unit 22b shown in FIG. 12 instead of the light source unit 22 described above.
- the light source unit 22b includes a light source section 66, a power supply section 68, a housing 110, a light transmission section 112, and a connecting section 114.
- the housing 110 has an accommodation space 116 that accommodates the light source section 66.
- the power supply section 68 is provided in the housing 110.
- the light transmission section 112 transmits the light L1 emitted by the light source section 66.
- the light transmission section 112 is, for example, an optical fiber.
- One end of the light transmission section 112 is attached to the housing 110.
- the other end of the light transmission section 112 is provided with a connecting section 114.
- the connecting section 114 has a connection section 118 that is detachable from the mounting section 64.
- the connection section 118 is configured in the same manner as the connection section 76 described above.
- the needle member 18 and catheter member 16 can be operated with the housing 110 and power supply unit 68 placed on the floor or the like. This makes it possible to prevent the needle member 18 from becoming difficult to operate even if the light source unit 66 and power supply unit 68 are made larger so that a sufficient amount of light L1 is guided to the tip 35 of the catheter shaft 28 (the tip of the linear portion 24).
- the blood vessel puncturing device 12A according to the first modified example will be described.
- the same components as those described above are given the same reference numerals, and detailed description will be omitted.
- the same components as those in the blood vessel puncturing device 12 described above have the same effects.
- the blood vessel puncture device 12A includes a catheter member 16, a needle member 18a, a blood flow blocking portion 20a, and a light source unit 22.
- the blood flow blocking portion 20a is detachable from the needle member 18a.
- the second engagement portion 58 is detachably fitted to the first engagement portion 50.
- connection force connection force between the first engaging portion 50 and the second engaging portion 58 is formed to be greater than the mating force (connection force) between the mounting portion 64 and the connection portion 76.
- connection force connection force
- the attachment structure of the needle hub 40 and the blood flow blocking portion 20a may be such that the first engagement portion 50 is a convex portion and the second engagement portion 58 is a concave portion (hole portion). Furthermore, the attachment structure is not limited to a fitting structure using convex and concave portions, but may be a claw engagement structure, a magnetic attraction structure, a hook-and-loop fastener engagement structure, a screw-threaded structure, etc.
- the first engaging portion 50, the second engaging portion 58, the mounting portion 64, and the connecting portion 76 are preferably formed so that the direction of the force acting on the blood flow blocking portion 20a when the blood flow blocking portion 20a is separated from the needle hub 40 is different from the direction of the force acting on the light source unit 22 when the light source unit 22 is separated from the blood flow blocking portion 20a. That is, for example, if the first engaging portion 50 and the second engaging portion 58 are of a fitting structure along the axial direction of the needle body 38, the mounting portion 64 and the connecting portion 76 are preferably formed of a screw-type screw structure. In such a case, the light source unit 22 can be easily removed from the blood flow blocking portion 20a while the blood flow blocking portion 20a is attached to the needle hub 40.
- the blood vessel puncture device 12A can be used in the following manner.
- a filter cap 400 blood flow blocking portion to which the light source unit 22 cannot be attached may be removably connected to the base end of the needle hub 40.
- the filter cap 400 is removed from the needle hub 40, and the blood flow blocking part 20a with the light source unit 22 attached is attached to the needle hub 40 as shown in Figures 14B and 15A. Then, after securing the blood vessel at the tip of the linear part 24 (needle body 38 and catheter shaft 28), the needle member 18a is removed from the catheter member 16 and the light source unit 22 is removed from the blood flow blocking part 20a (see Figure 15B). The removed light source unit 22 is reused. The needle member 18a and the blood flow blocking part 20a attached to the needle hub 40 are discarded together.
- the blood flow blocking section 20a is detachable from the base end of the needle hub 40.
- the filter cap 400 can be replaced with a blood flow blocking section 20a to which the light source unit 22 can be attached.
- the blood vessel puncture device 12A may be equipped with light source units 22a and 22b instead of the light source unit 22.
- the blood vessel puncture device 12B includes a catheter member 16, a needle member 18b, a blood flow blocking section 20, and a light source unit 22.
- the needle member 18b has a needle body 38a and a needle hub 40.
- the inner peripheral surface of the needle body 38a is coated with a reflecting section 130 (reflective film) for reflecting the light L1 emitted by the light source section 66.
- the inner peripheral surface (inner surface) of the needle body 38a includes both a portion located in the range from the base end of the needle body 38a to the base end of the tip opening 46 and a portion located in the range from the base end of the tip opening 46 to the tip of the tip opening 46.
- the reflecting section 130 is also provided on the inner surface of the needle body 38a that is visible through the tip opening 46 from the outside of the needle body 38a.
- the light L1 emitted by the light source unit 66 is guided in the order of the light guide hole 78, the filter 56, the blood flow path 60, the lumen 52 of the needle hub 40, and the lumen 42 of the needle body 38a.
- the light L1 introduced into the lumen 42 of the needle body 38a is guided toward the tip while reflecting off the reflector 130 provided on the inner surface of the needle body 38a, and is guided out from the tip opening 46 of the needle body 38a.
- the light guide hole 78, the filter 56, the blood flow path 60, the lumen 52 of the needle hub 40, and the lumen 42 of the needle body 38a form an optical path 134 that guides the light L1 emitted by the light source unit 66 to the tip of the needle body 38a.
- a large amount of light L1 can be guided out from the tip opening 46 of the needle body 38a.
- the light L1 emitted by the light source unit 66 is also guided to the tip 35 of the catheter shaft 28.
- the light L1 emitted by the light source unit 66 is guided out from the tip opening 46 of the needle body 38a and the tip 35 of the catheter shaft 28.
- the light L1 does not have to be guided out from the tip 35 of the catheter shaft 28.
- the tip opening 46 of the needle body 38a and the tip 35 of the catheter shaft 28 are displayed most brightly (white) (see Figure 17).
- the tip opening 46 of the needle body 38a when the tip opening 46 of the needle body 38a is inserted into the blood vessel 302 but the tip 35 of the catheter shaft 28 is not inserted into the blood vessel 302, the tip opening 46 of the needle body 38a appears dark in the received light image 90 while the tip 35 of the catheter shaft 28 appears bright (white) (see FIG. 6). Then, when the tip opening 46 of the needle body 38a and the tip 35 of the catheter shaft 28 are inserted into the blood vessel 302, the tip 35 of the catheter shaft 28 also appears dark in the received light image 90 (see FIG. 8).
- the light L1 emitted by the light source unit 66 is guided through the inner cavity 42 of the needle body 38a and is guided out from the tip opening 46 of the needle body 38a.
- the inner surface of the needle body 38a is provided with a reflecting portion 130 that reflects the light L1 emitted by the light source portion 66.
- the light L1 emitted by the light source unit 66 can be efficiently guided to the tip opening 46 of the needle body 38a.
- the blood vessel puncture device 12B may have a blood flow blocking section 20b shown in FIG. 18 instead of the blood flow blocking section 20.
- the blood flow blocking section 20b includes a support section 140 and a filter 142.
- the support section 140 has a plurality of blood flow paths 144. These blood flow paths 144 are located on the outer periphery of the support section 140.
- the central section 146 of the support section 140 is closed by a wall section.
- the central section 146 of the support section 140 is transparent so that the light L1 emitted by the light source section 66 can pass through.
- Each blood flow path 144 extends from the distal end surface of the support part 140 (the distal end surface of the second engagement part 58) to the proximal end surface of the support part 140.
- the multiple blood flow paths 144 are arranged at intervals in the circumferential direction of the support part 140.
- the filter 142 is fixed to the proximal end surface of the support part 140 so as to cover the proximal end openings of the multiple blood flow paths 144.
- the filter 142 extends in an annular shape (e.g., annular).
- the lumen 52 of the needle hub 40 and the multiple blood flow paths 144 form a blood inlet portion 148 for checking flashback.
- the light L1 emitted by the light source section 66 passes through the center section 146 of the support section 140 (without passing through the filter 142) and is guided to the lumen 52 of the needle hub 40.
- the filter 142 is not limited to materials that transmit the light L1, making it easy to select the material for the filter 142.
- the blood vessel puncture device 12B may be equipped with light source units 22a and 22b instead of the light source unit 22.
- the blood flow blocking unit 20 may be detachable from the base end of the needle hub 40.
- a blood vessel puncture device 12C includes a catheter member 16, a needle member 18c, a blood flow blocking portion 20c, a light source unit 22, and a light guiding member 150.
- the needle member 18c includes a needle body 38 and a needle hub 40a.
- the needle hub 40a has a needle connection hole 48, a lumen 52, a blood inlet 152 for checking flashback, a first engagement portion 50, and a filter 154.
- the inner peripheral surface of the needle hub 40a is provided with a guide surface 132 for guiding the light guide member 150 to the lumen 42 of the needle body 38.
- the guide surface 132 tapers toward the needle body 38 (tip direction).
- the base end of the needle body 38 is located further distally than the base end of the needle connection hole 48.
- the lumen 52 of the needle hub 40a is connected to the base end of the needle connection hole 48.
- the blood inlet 152 includes a first opening 156 that opens into the inner peripheral surface of the needle connection hole 48 and a second opening 158 that opens into the base end surface of the needle hub 40a.
- the first opening 156 is located in the proximal direction from the proximal end of the needle body 38.
- the second opening 158 is covered by a filter 154 that is fixed to the proximal surface of the needle hub 40a.
- the filter 154 allows air to pass through while preventing blood from passing through.
- the blood flow blocking portion 20c includes a support portion 160.
- the support portion 160 has a second engagement portion 58, an attachment portion 64, and an insertion hole 162.
- the second engagement portion 58 fits into the first engagement portion 50 in a liquid-tight and air-tight manner.
- the light guide member 150 is inserted into the insertion hole 162.
- the insertion hole 162 extends from the tip surface of the support portion 160 (the tip surface of the second engagement portion 58) to the attachment portion 64.
- the insertion hole 162 is located on an extension of the axis of the needle body 38.
- the blood flow blocking portion 20c is detachable from the base end portion of the needle hub 40a.
- the light-guiding member 150 extends linearly along the axial direction of the needle body 38.
- the light-guiding member 150 is located on the axis of the needle body 38.
- the light-guiding member 150 is inserted into the inner cavity 42 of the needle body 38.
- the tip of the light-guiding member 150 is located near the tip opening 46 of the needle body 38.
- the tip surface of the light-guiding member 150 faces the tip opening 46 of the needle body 38.
- the outer diameter of the light-guiding member 150 is smaller than the inner diameter of the needle body 38.
- a flow path 168 for guiding blood in the base end direction is formed between the outer peripheral surface of the light-guiding member 150 and the inner peripheral surface of the needle body 38.
- the flow path 168 extends from the tip of the light-guiding member 150 to the base end of the needle body 38.
- the base end of the light-guiding member 150 is supported by the support portion 160.
- the base end of the light-guiding member 150 is fixed to the support portion 160 while being inserted into the insertion hole 162.
- the light-guiding member 150 may be removable from the support portion 160.
- the base end surface of the light guide member 150 faces the light guide hole 78 when the light source unit 22 is attached to the attachment portion 64.
- the light guide member 150 is provided continuously from the tip of the needle body 38 to the blood flow blocking portion 20c.
- the light guide member 150 may be provided discontinuously from the tip of the needle body 38 to the blood flow blocking portion 20c.
- the light guide member 150 is formed solid. Examples of the light guide member 150 include an optical fiber, an acrylic rod, a glass rod, and a light emitting tube.
- the area of the first opening 156 of the blood inlet 152 is larger than the cross-sectional area of the annular flow path formed between the outer peripheral surface of the light-guiding member 150 and the inner peripheral surface of the needle connection hole 48 in the proximal direction from the first opening 156 of the needle connection hole 48. Therefore, blood guided from the inner cavity 42 of the needle body 38 to the needle connection hole 48 flows preferentially into the blood inlet 152. In other words, blood can be effectively prevented from flowing into the inner cavity 52 of the needle hub 40a.
- the above-mentioned filter cap 400 (see FIG. 14A) is removed from the base end of the needle hub 40a, and the blood flow blocking portion 20c to which the light guiding member 150 is attached is attached to the base end of the needle hub 40a.
- the light guiding member 150 is inserted into the inner cavity 42 of the needle body 38 while being guided by the guide surface 132.
- the light guiding member 150 may be inserted alone into the inner cavity 42 of the needle body 38, and then the light guiding member 150 may be bonded (attached) to the blood flow blocking portion 20c.
- the light L1 emitted by the light source unit 66 is guided to the tip opening 46 of the needle body 38 via the light guide hole 78 and the light guide member 150.
- the light guide hole 78 and the light guide member 150 form a light path 170 that guides the light L1 emitted by the light source unit 66 to the tip of the needle body 38.
- a large amount of light L1 can be guided out from the tip opening 46 of the needle body 38.
- the light L1 emitted by the light source unit 66 is also guided to the tip 35 of the catheter shaft 28.
- the light L1 emitted by the light source unit 66 is guided out from the tip opening 46 of the needle body 38 and the tip 35 of the catheter shaft 28.
- the light L1 does not have to be guided out from the tip 35 of the catheter shaft 28.
- the appearance of the received light image 90 is similar to that of the blood vessel puncture device 12B of the second modified example, so a description thereof will be omitted.
- the optical path 170 includes a light-guiding member 150 for guiding the light L1 from the light source unit 22 to the tip of the needle body 38.
- the light L1 emitted by the light source unit 66 can be guided out from the tip opening 46 of the needle body 38.
- the tip of the light-guiding member 150 is positioned at the tip of the needle body 38 when inserted into the inner cavity 42 of the needle body 38.
- the light L1 emitted by the light source unit 66 can be efficiently guided to the tip opening 46 of the needle body 38.
- the base end of the light-guiding member 150 is supported by the blood flow blocking section 20c.
- This configuration prevents the base end of the light-guiding member 150 from shifting relative to the blood flow blocking portion 20c, so that the light L1 emitted by the light source 66 can be efficiently guided to the light-guiding member 150.
- the blood flow blocking portion 20c is detachable from the base end of the needle hub 40a.
- the inner surface of the needle hub 40a is provided with a guide surface 132 for guiding the light guide member 150 into the inner cavity 42 of the needle body 38 when the blood flow blocking portion 20c is attached to the base end of the needle hub 40a.
- the guide surface 132 tapers toward the needle body 38.
- the guide surface 132 allows the light guide member 150 to be smoothly inserted into the inner cavity 42 of the needle body 38.
- the blood vessel puncture device 12C may be equipped with light source units 22a and 22b instead of the light source unit 22.
- the blood flow blocking portion 20c may be fixed to the base end of the needle hub 40a.
- a blood vessel puncture device 12D includes a catheter member 16, a needle member 18d, a blood flow blocking unit 20d, a light source unit 22, and a light guiding member 150a.
- the blood flow blocking unit 20d includes a support member 180 and a filter 56.
- Needle member 18d has a needle body 38 and a needle hub 40b.
- the inner peripheral surface of needle hub 40b is provided with the above-mentioned guide surface 132.
- the support part 180 has a second engagement part 58, an attachment part 64, an insertion hole 182, and a blood inlet part 184 for checking flashback.
- the light guide member 150a is inserted into the insertion hole 182.
- the insertion hole 182 opens to the distal end surface of the support part 180 (the distal end surface of the second engagement part 58). In other words, the insertion hole 182 is connected to the inner cavity 52 of the needle hub 40b.
- the blood inlet part 184 is connected to the base end of the insertion hole 182.
- the filter 56 is supported by the support part 180 so as to prevent blood in the blood inlet part 184 from flowing to the attachment part 64.
- the light-guiding member 150a is formed in a tubular shape.
- the light-guiding member 150a is made of acrylic, glass, a light-emitting tube, or the like.
- the light-guiding member 150a extends linearly along the axial direction of the needle body 38.
- the light-guiding member 150a is located on the axis of the needle body 38.
- the light-guiding member 150a is inserted into the inner cavity 42 of the needle body 38.
- the tip of the light-guiding member 150a is located near the tip opening 46 of the needle body 38.
- the tip surface of the light-guiding member 150a faces the tip opening 46 of the needle body 38.
- the outer peripheral surface of the light-guiding member 150a is in liquid-tight contact with the inner peripheral surface of the needle body 38. However, the outer peripheral surface of the light-guiding member 150a may be spaced from the inner peripheral surface of the needle body 38.
- the base end of the light-guiding member 150a is supported by the support portion 180.
- the base end of the light-guiding member 150a is fixed to the support portion 180 while inserted into the insertion hole 182.
- the light-guiding member 150a may be removable from the support portion 180.
- the base end surface of the light-guiding member 150a is located on the optical axis of the light source portion 66.
- the base end of the inner cavity 151 of the light-guiding member 150a is connected to the blood inlet portion 184.
- the above-mentioned filter cap 400 (see FIG. 14A) is removed from the base end of the needle hub 40b, and the blood flow blocking section 20d to which the light guiding member 150a is attached is attached to the base end of the needle hub 40b.
- the light guiding member 150a is inserted into the lumen 42 of the needle body 38 while being guided by the guide surface 132.
- the light guiding member 150a may be inserted alone into the lumen 42 of the needle body 38, and then the light guiding member 150a may be adhered (attached) to the blood flow blocking section 20d.
- the light L1 emitted by the light source unit 66 is guided to the tip opening 46 of the needle body 38 via the light guide hole 78, the filter 56, the blood inlet section 184, and the light guide member 150a.
- the light guide hole 78, the filter 56, the blood inlet section 184, and the light guide member 150a form an optical path 186 that guides the light L1 emitted by the light source unit 66 to the tip of the needle body 38.
- a vascular puncture device 12D when the light source unit 66 emits highly directional light L1 (e.g., laser light, etc.), a large amount of light L1 can be guided out from the tip opening 46 of the needle body 38.
- the light L1 emitted by the light source unit 66 is also guided to the tip 35 of the catheter shaft 28.
- the light L1 emitted by the light source unit 66 is guided out from the tip opening 46 of the needle body 38 and the tip 35 of the catheter shaft 28.
- the light L1 does not have to be guided out from the tip 35 of the catheter shaft 28.
- the appearance of the received light image 90 is similar to that of the blood vessel puncture device 12B of the second modified example, and therefore a description thereof will be omitted.
- the same configuration as the blood vessel puncture device 12C described above provides the same effects.
- the blood vessel puncture device 12D may be equipped with light source units 22a and 22b instead of the light source unit 22.
- the blood flow blocking portion 20d may be fixed to the base end of the needle hub 40b.
- a blood vessel puncture device 12E includes a catheter member 16, a needle member 18e, a blood flow blocking portion 20e, a light source unit 22, and a light guiding member 150.
- the needle member 18e includes a needle body 38 and a needle hub 40c.
- the blood flow blocking portion 20e is liquid-tightly attached to the base end of the needle hub 40c and is movable along the axial direction of the needle body 38.
- the base end (first engagement portion 50) of the needle hub 40c is provided with a female thread portion 41.
- the configuration of the needle hub 40c other than the female thread portion 41 is the same as that of the needle hub 40a described above.
- the tip end (second engagement portion 58) of the blood flow blocking portion 20e is provided with a male thread portion 21 that screws into the female thread portion 41.
- the configuration of the blood flow blocking portion 20e other than the male thread portion 21 is the same as that of the blood flow blocking portion 20c described above.
- the tip position of the light-guiding member 150 relative to the tip opening 46 of the needle body 38 can be displaced in the axial direction of the needle body 38 by rotating the blood flow blocking portion 20e relative to the needle hub 40c. That is, the male thread portion 21 and the female thread portion 41 function as a position adjustment mechanism for adjusting the tip position of the light-guiding member 150 relative to the tip opening 46 in the axial direction of the needle body 38.
- the male thread portion 21 is in liquid-tight contact with the female thread portion 41. That is, the male thread portion 21 and the female thread portion 41 also have the function of preventing blood from leaking between the needle hub 40c and the blood flow blocking portion 20e.
- the light-guiding member 150 protrudes from the tip opening 46.
- the tip of the light-guiding member 150 is located between the tip of the needle body 38 and the base end of the tip opening 46. This allows the tip of the needle body 38 to emit light efficiently while suppressing the puncture resistance of the needle body 38.
- the tip position of the light-guiding member 150 may deviate from the appropriate position (position in FIG. 21) due to manufacturing tolerances of the blood vessel puncture device 12E (assembly tolerances, variation in the length of the light-guiding member 150, etc.). If the tip of the light-guiding member 150 is located more distally than the tip of the needle body 38, the puncture resistance increases. Also, if the tip of the light-guiding member 150 is located more proximally than the proximally of the tip opening 46, the amount of light guided from the tip opening 46 decreases. The deviation from the appropriate position of the tip of the light-guiding member 150 due to manufacturing tolerances is 1 mm or less.
- the tip of the light-guiding member 150 can be adjusted to the appropriate position.
- the male thread portion 21 and the female thread portion 41 maintain a liquid-tight contact state. In other words, blood leakage between the male thread portion 21 and the female thread portion 41 can be prevented.
- the blood vessel puncture device 12E may be provided with a locking mechanism that prevents the blood flow blocking portion 20e from rotating relative to the needle hub 40c after the tip position of the light guiding member 150 has been adjusted. In this case, it is possible to prevent the tip of the light guiding member 150 from shifting from the appropriate position when the blood vessel puncture device 12E is in use, etc.
- a sealing member (not shown) that prevents blood from leaking between the blood flow blocking portion 20e and the needle hub 40c may be provided on the base end side of the male thread portion 21 in the second engagement portion 58.
- An example of such a sealing member is an annular rubber seal.
- the blood flow blocking portion 20e is liquid-tightly attached to the base end of the needle hub 40c and can move along the axial direction of the needle body 38.
- a female thread portion 41 is provided at the base end of the needle hub 40c, and a male thread portion 21 that screws into the female thread portion 41 is provided at the tip end of the blood flow blocking portion 20e.
- the male thread portion 21 is in liquid-tight contact with the female thread portion 41.
- the seal member does not increase the rotational resistance of the blood flow blocking portion 20e relative to the needle hub 40c, making it easy to adjust the tip position of the light-guiding member 150.
- the present invention is not limited to the above disclosure, and various configurations may be adopted without departing from the gist of the present invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
A blood vessel piercing device (12) of a blood vessel piercing system (10) is provided with: a blood circulation blocking part (20); a light source unit (22); and an optical path (26). Light (L1) emitted from a light source (66) is guided outside from the leading end of a linear part (24). A blood inlet (62) for flashback confirmation to which blood flowing in through a leading end opening (46) of a needle body (38) is introduced is provided to at least one of a needle hub (40) and the blood circulation blocking part (20). The blood circulation blocking part (20) is formed so as to block circulation of blood to a fitting part (64).
Description
本発明は、血管穿刺デバイス及び血管穿刺システムに関する。
The present invention relates to a vascular puncture device and a vascular puncture system.
例えば、国際公開第2022/176880号には、生体部位の血管に穿刺可能な線状部(針体及びカテーテルシャフト)を備えた血管穿刺デバイスが開示されている。血管穿刺デバイスは、針体の基端部に設けられた針ハブと、針ハブの基端部に着脱可能に設けられた光源ユニットとを備える。光源ユニットが針ハブの基端部に装着された状態で、針体の基端部は光源ユニットに接続される。針体の内腔には、血液の光源ユニットへの流入を阻止する閉塞部材が設けられている。光源ユニットの光源部が発した光は、閉塞部材を透過して針体の先端開口から導出する。
For example, WO 2022/176880 discloses a blood vessel puncture device equipped with a linear portion (needle body and catheter shaft) capable of puncturing a blood vessel in a living body. The blood vessel puncture device includes a needle hub provided at the base end of the needle body, and a light source unit detachably provided at the base end of the needle hub. With the light source unit attached to the base end of the needle hub, the base end of the needle body is connected to the light source unit. An obstruction member that prevents blood from flowing into the light source unit is provided in the inner cavity of the needle body. Light emitted by the light source portion of the light source unit passes through the obstruction member and is guided out from the tip opening of the needle body.
このような血管穿刺デバイスにおいて、針体の先端開口から導出した光は、血液によって吸収されたり減衰したりするため、針体の血管確保の前後で、生体部位の外側で受光又は視認できる光の強度が変化する。そのため、光源部が発した光に基づいて針体の血管確保を簡単且つ速やかに知ることができる。
In such a blood vessel puncture device, the light emitted from the tip opening of the needle body is absorbed or attenuated by the blood, so the intensity of the light received or visible outside the body part changes before and after the needle body secures the blood vessel. Therefore, it is possible to easily and quickly know whether the needle body has secured the blood vessel based on the light emitted by the light source unit.
ところで、太い血管や皮膚からの距離が近い血管に線状部を穿刺する場合には、光源ユニットが発した光によらなくても、線状部の血管確保を簡単に判断できることもある。上述した国際公開第2022/176880号のように光源ユニットを針ハブに対して着脱可能であれば、状況に応じて光源ユニットを使用するか否かを選択でき便利である。また、比較的高価である光源ユニットを再利用でき、血管穿刺手技を実施するためのデバイスの費用を抑えることができる。
Incidentally, when inserting a linear portion into a thick blood vessel or a blood vessel close to the skin, it may be possible to easily determine whether the blood vessel has been secured in the linear portion without relying on the light emitted by the light source unit. If the light source unit is detachable from the needle hub as in the above-mentioned International Publication No. 2022/176880, it is convenient to be able to select whether or not to use the light source unit depending on the situation. In addition, the light source unit, which is relatively expensive, can be reused, reducing the cost of the device for performing the blood vessel puncture procedure.
一方、上述した国際公開第2022/176880号では、針体の内腔が閉塞部材によって閉塞されている。すなわち、針ハブは、針体の血管確保を確認するための血液流入部(フラッシュバック確認用の血液流入部)を有していない。フラッシュバック確認用の血液流入部を有する針ハブを用いる場合、血液流入部に流入した血液が光源ユニットに触れる可能性があり、血液に触れた光源ユニットは再利用できないという問題がある。
On the other hand, in the above-mentioned WO 2022/176880, the inner cavity of the needle body is blocked by a blocking member. In other words, the needle hub does not have a blood inlet portion (blood inlet portion for checking flashback) for confirming that the needle body has secured a blood vessel. When using a needle hub having a blood inlet portion for checking flashback, there is a problem that blood flowing into the blood inlet portion may come into contact with the light source unit, and the light source unit that has come into contact with blood cannot be reused.
本発明は、上述した課題を解決することを目的とする。
The present invention aims to solve the above-mentioned problems.
(1)本発明の一態様は、生体部位の血管に穿刺可能な線状部を備え、当該線状部は管状の針体を含み、前記針体の基端部には針ハブが設けられた血管穿刺デバイスであって、前記針ハブの基端部に設けられた血液流通阻止部と、光を発する光源部を有し、且つ前記血液流通阻止部の装着部に着脱可能である光源ユニットと、前記光源部が発した前記光を前記線状部の先端部に導く光路と、を備え、前記光源部が発した前記光は、前記線状部の前記先端部から外部に導出され、前記針ハブ及び前記血液流通阻止部の少なくともいずれかには、前記針体の先端開口から流入した血液が導かれるフラッシュバック確認用の血液流入部が設けられ、前記血液流通阻止部は、前記血液の前記装着部への流通が阻止されるように形成されている、血管穿刺デバイスである。
(1) One aspect of the present invention is a blood vessel puncture device having a linear part capable of puncturing a blood vessel at a living body part, the linear part including a tubular needle body, and a needle hub provided at the base end of the needle body, the blood vessel puncture device comprising a blood flow blocking part provided at the base end of the needle hub, a light source unit having a light source part that emits light and is detachable to an attachment part of the blood flow blocking part, and an optical path that guides the light emitted by the light source part to the tip end of the linear part, the light emitted by the light source part is guided to the outside from the tip end of the linear part, at least one of the needle hub and the blood flow blocking part is provided with a blood inflow part for checking flashback, through which blood flowing in from the tip opening of the needle body is guided, and the blood flow blocking part is formed so as to prevent the blood from flowing to the attachment part.
(2)項目(1)記載の血管穿刺デバイスであって、前記光源ユニットが前記装着部に装着された状態で、前記光源部は、前記線状部の先端方向に向かって前記光を発してもよい。
(2) In the blood vessel puncture device described in item (1), when the light source unit is attached to the attachment portion, the light source portion may emit the light toward the tip of the linear portion.
(3)項目(1)又は(2)に記載の血管穿刺デバイスであって、前記光源ユニットは、前記光源部を収容するハウジングを有し、前記ハウジングは、前記装着部に着脱可能な接続部を有してもよい。
(3) In the blood vessel puncture device described in item (1) or (2), the light source unit may have a housing that houses the light source section, and the housing may have a connection section that is detachable from the attachment section.
(4)項目(1)~(3)のいずれか1つに記載の血管穿刺デバイスであって、前記血液流通阻止部は、前記針ハブの前記基端部に固定されてもよい。
(4) In the blood vessel puncture device described in any one of items (1) to (3), the blood flow blocking portion may be fixed to the base end of the needle hub.
(5)項目(1)~(3)のいずれか1つに記載の血管穿刺デバイスであって、前記血液流通阻止部は、前記針ハブの前記基端部に着脱可能であってもよい。
(5) In the blood vessel puncture device described in any one of items (1) to (3), the blood flow blocking portion may be detachable from the base end of the needle hub.
(6)項目(1)~(5)のいずれか1つに記載の血管穿刺デバイスであって、前記光源部が発した前記光は、前記針体の内腔を介して当該針体の前記先端開口から導出されてもよい。
(6) In the blood vessel puncture device described in any one of items (1) to (5), the light emitted by the light source unit may be guided out from the tip opening of the needle body through the inner cavity of the needle body.
(7)項目(6)記載の血管穿刺デバイスであって、前記針体の内面には、前記光源部が発した前記光が反射する反射部が設けられてもよい。
(7) In the blood vessel puncture device described in item (6), the inner surface of the needle body may be provided with a reflecting portion that reflects the light emitted by the light source unit.
(8)項目(6)記載の血管穿刺デバイスであって、前記光路は、前記光源部が発した前記光を前記針体の先端部に導くための導光部材を含んでもよい。
(8) In the blood vessel puncture device described in item (6), the optical path may include a light-guiding member for guiding the light emitted by the light source unit to the tip of the needle body.
(9)項目(8)記載の血管穿刺デバイスであって、前記導光部材の先端部は、前記針体の前記内腔に挿入された状態で当該針体の前記先端部に位置してもよい。
(9) In the blood vessel puncture device described in item (8), the tip of the light-guiding member may be positioned at the tip of the needle body when inserted into the inner cavity of the needle body.
(10)項目(8)又は(9)に記載の血管穿刺デバイスであって、前記導光部材の基端部は、前記血液流通阻止部に支持されてもよい。
(10) In the blood vessel puncture device described in item (8) or (9), the base end of the light-guiding member may be supported by the blood flow blocking portion.
(11)項目(10)記載の血管穿刺デバイスであって、前記血液流通阻止部は、前記針ハブの前記基端部に着脱可能であり、前記針ハブの内面には、前記血液流通阻止部を前記針ハブの前記基端部に装着する時に前記導光部材を前記針体の前記内腔に導くための案内面が設けられ、前記案内面は、前記針体に向かってテーパー状に縮径してもよい。
(11) In the blood vessel puncture device described in item (10), the blood flow blocking section is detachable from the base end of the needle hub, and the inner surface of the needle hub is provided with a guide surface for guiding the light guiding member into the inner cavity of the needle body when the blood flow blocking section is attached to the base end of the needle hub, and the guide surface may taper in diameter toward the needle body.
(12)項目(1)~(11)のいずれか1つに記載の血管穿刺デバイスであって、前記血液流通阻止部は、前記血液流入部から前記装着部への前記血液の流通を阻止するフィルターと、前記フィルターを支持する支持部と、を備え、前記装着部は、前記支持部の基端部に設けられてもよい。
(12) In the blood vessel puncture device described in any one of items (1) to (11), the blood flow blocking section includes a filter that blocks the flow of blood from the blood inlet section to the attachment section, and a support section that supports the filter, and the attachment section may be provided at the base end of the support section.
(13)項目(1)~(12)のいずれか1つに記載の血管穿刺デバイスであって、前記光源部は、近赤外光を含む前記光を発してもよい。
(13) In the vascular puncture device described in any one of items (1) to (12), the light source unit may emit light that includes near-infrared light.
(14)項目(1)~(13)のいずれか1つに記載の血管穿刺デバイスであって、前記針体が挿通する内腔を有する管状のカテーテルシャフトと、前記カテーテルシャフトの基端部に設けられて前記針体が挿通する内腔を有するカテーテルハブと、を備え、前記線状部は、前記針体と前記カテーテルシャフトとを含んでもよい。
(14) A blood vessel puncture device according to any one of items (1) to (13), comprising a tubular catheter shaft having a lumen through which the needle body is inserted, and a catheter hub provided at the base end of the catheter shaft and having a lumen through which the needle body is inserted, and the linear portion may include the needle body and the catheter shaft.
(15)項目(14)記載の血管穿刺デバイスであって、前記光路は、前記血液流通阻止部の壁部、前記針ハブの壁部、前記カテーテルハブの壁部及び前記カテーテルシャフトの壁部に設けられ、前記光源部が発した光は、前記カテーテルシャフトの先端部から前記外部に導出されてもよい。
(15) In the blood vessel puncture device described in item (14), the optical path may be provided in the wall of the blood flow blocking portion, the wall of the needle hub, the wall of the catheter hub, and the wall of the catheter shaft, and the light emitted by the light source may be guided to the outside from the tip of the catheter shaft.
(16)項目(15)記載の血管穿刺デバイスであって、前記血液流通阻止部の壁部、前記針ハブの壁部、前記カテーテルハブの壁部及び前記カテーテルシャフトの壁部の各々の外周面には、前記光源部が発した前記光の透過を抑制する光透過抑制部が設けられてもよい。
(16) In the blood vessel puncture device described in item (15), a light transmission suppression section that suppresses the transmission of the light emitted by the light source section may be provided on the outer peripheral surface of each of the wall section of the blood flow blocking section, the wall section of the needle hub, the wall section of the catheter hub, and the wall section of the catheter shaft.
(17)項目(10)記載の血管穿刺デバイスであって、前記血液流通阻止部は、前記針ハブの前記基端部に対して液密に装着された状態で前記針体の軸線方向に沿って移動可能であってもよい。
(17) In the blood vessel puncture device described in item (10), the blood flow blocking portion may be movable along the axial direction of the needle body while being liquid-tightly attached to the base end of the needle hub.
(18)項目(17)記載の血管穿刺デバイスであって、前記針ハブの前記基端部には、雌ねじ部が設けられ、前記血液流通阻止部の先端部には、前記雌ねじ部に螺合する雄ねじ部が設けられてもよい。
(18) In the blood vessel puncture device described in item (17), the base end of the needle hub may be provided with a female thread portion, and the tip end of the blood flow blocking portion may be provided with a male thread portion that screws into the female thread portion.
(19)項目(18)記載の血管穿刺デバイスであって、前記雄ねじ部は、前記雌ねじ部に対して液密に接触してもよい。
(19) In the vascular puncture device described in item (18), the male threaded portion may be in liquid-tight contact with the female threaded portion.
(20)本発明の他の態様は、項目(1)~(19)のいずれか1つに記載の血管穿刺デバイスと、前記線状部の前記先端部から導出された前記光を受光する受光部と、前記受光部が受光した前記光に基づいて作成された受光画像を表示する画像表示部と、を備える、血管穿刺システムである。
(20) Another aspect of the present invention is a blood vessel puncture system comprising a blood vessel puncture device according to any one of items (1) to (19), a light receiving unit that receives the light emitted from the tip of the linear portion, and an image display unit that displays a received light image created based on the light received by the light receiving unit.
本発明によれば、血液流通阻止部の装着部に光源ユニットが着脱可能であるため、状況に応じて光源ユニットを使用するか否かを選択できる。また、光源ユニットを使用する場合、光源ユニットが発した光は、光路を介して線状部の先端部に導かれる。線状部の血管確保前の状態では、線状部の先端部から導出された光は、生体組織(血管以外の皮下組織等)を透過して生体部位の外側に導かれる。一方、線状部の血管確保の状態では、線状部の先端部から導出された光は、血液に吸収されたり血液を透過する時に減衰したりする。つまり、線状部の血管確保の前後で、生体部位の外側で受光又は視認できる光の強度が変化するため、光源部が発した光に基づいて線状部の血管確保を簡単且つ速やかに知ることができる。
According to the present invention, since the light source unit is detachable from the attachment part of the blood flow blocking part, it is possible to select whether or not to use the light source unit depending on the situation. Furthermore, when the light source unit is used, the light emitted by the light source unit is guided to the tip of the linear part via the optical path. When the linear part is in a state before the blood vessel is secured, the light derived from the tip of the linear part passes through the biological tissue (subcutaneous tissue other than the blood vessel, etc.) and is guided to the outside of the biological part. On the other hand, when the blood vessel is secured by the linear part, the light derived from the tip of the linear part is absorbed by the blood or attenuated when passing through the blood. In other words, the intensity of the light received or visible outside the biological part changes before and after the blood vessel is secured by the linear part, so it is possible to easily and quickly know whether the blood vessel is secured by the linear part based on the light emitted by the light source part.
さらに、針体の血管確保により血液が血液流入部に流入するため、ユーザは、血液流入部への血液の流入を視認することにより針体の血管確保を精度よく知ることができる。この時、装着部への血液の流通は血液流通阻止部によって阻止されている。そのため、装着部に装着されている光源ユニットが血液に触れることはない。従って、光源ユニットを再利用できる。
Furthermore, because blood flows into the blood inlet section when the needle body secures a blood vessel, the user can accurately tell whether the needle body has secured a blood vessel by visually checking the blood flow into the blood inlet section. At this time, the blood flow to the attachment section is blocked by the blood flow blocking section. Therefore, the light source unit attached to the attachment section does not come into contact with blood. Therefore, the light source unit can be reused.
図1に示すように、本発明の一実施形態に係る血管穿刺システム10は、血管穿刺デバイス12と可視化装置14とを備える。血管穿刺デバイス12は、生体部位300の血管302内に輸液(薬液)を投与するための留置針(末梢動静脈用留置針、透析用留置針等)として構成されている(図7参照)。ただし、血管穿刺デバイス12は、末梢挿入型中心静脈カテーテル(PICC:Peripherally Inserted Central venous Catheter)、ミッドラインカテーテル、中心静脈カテーテルの血管アクセス製品であってもよい。また、血管穿刺デバイス12は、カテーテルを有しない採血針であってもよい。
As shown in FIG. 1, a vascular puncture system 10 according to one embodiment of the present invention includes a vascular puncture device 12 and a visualization device 14. The vascular puncture device 12 is configured as an indwelling needle (peripheral arterial and venous indwelling needle, dialysis indwelling needle, etc.) for administering an infusion (medicinal solution) into a blood vessel 302 of a living body part 300 (see FIG. 7). However, the vascular puncture device 12 may also be a vascular access product such as a peripherally inserted central venous catheter (PICC), a midline catheter, or a central venous catheter. The vascular puncture device 12 may also be a blood collection needle without a catheter.
図1~図3に示すように、血管穿刺デバイス12は、カテーテル部材16、針部材18、血液流通阻止部20及び光源ユニット22を備える。カテーテル部材16、針部材18及び血液流通阻止部20は、一回の使用で廃棄されるディスポーザブル品(使い捨て品)である。光源ユニット22は、複数回使用することができるリユース品である。
As shown in Figures 1 to 3, the vascular puncture device 12 comprises a catheter member 16, a needle member 18, a blood flow blocking portion 20, and a light source unit 22. The catheter member 16, the needle member 18, and the blood flow blocking portion 20 are disposable items that are discarded after a single use. The light source unit 22 is a reusable item that can be used multiple times.
血管穿刺デバイス12は、初期状態で、生体部位300の血管302に穿刺可能な線状部24を有する。図3において、線状部24は、カテーテル部材16の管状のカテーテルシャフト28の内腔32に針部材18の管状の針体38が挿通されることによって形成されている。すなわち、線状部24は、二重管構造を有する。血管穿刺デバイス12は、当該血管穿刺デバイス12の基端部に位置する光源ユニット22の光源部66が発した光L1を線状部24の先端部に導く光路26を備える。
In its initial state, the vascular puncture device 12 has a linear portion 24 capable of puncturing a blood vessel 302 in a biological site 300. In FIG. 3, the linear portion 24 is formed by inserting the tubular needle body 38 of the needle member 18 into the lumen 32 of the tubular catheter shaft 28 of the catheter member 16. In other words, the linear portion 24 has a double tube structure. The vascular puncture device 12 has an optical path 26 that guides light L1 emitted by the light source portion 66 of the light source unit 22 located at the base end of the vascular puncture device 12 to the tip of the linear portion 24.
図2及び図3に示すように、カテーテル部材16は、可撓性を有するカテーテルシャフト28と、カテーテルシャフト28の基端部に設けられたカテーテルハブ30とを有する。カテーテルシャフト28は、生体部位300の血管302内に持続的に挿入可能な管状部材である。カテーテルシャフト28は、その全長に亘って軸線方向に沿って延在した内腔32(薬液供給路)を有する。カテーテルシャフト28の先端には、内腔32に連通する先端開口34が形成されている。
As shown in Figures 2 and 3, the catheter member 16 has a flexible catheter shaft 28 and a catheter hub 30 provided at the base end of the catheter shaft 28. The catheter shaft 28 is a tubular member that can be continuously inserted into a blood vessel 302 of a biological site 300. The catheter shaft 28 has an inner lumen 32 (medicinal solution supply path) that extends axially over its entire length. A tip opening 34 that communicates with the inner lumen 32 is formed at the tip of the catheter shaft 28.
カテーテルシャフト28の構成材料としては、例えば、ポリテトラフルオロエチレン(PTFE)、エチレン・テトラフルオロエチレン共重合体(ETFE)、ペルフルオロアルコキシフッ素樹脂(PFA)等のフッ素系樹脂、ポリエチレン、ポリプロピレン等のオレフィン系樹脂又はこれらの混合物、ポリウレタン、ポリエステル、ポリアミド、ポリエーテルナイロン樹脂、オレフィン系樹脂とエチレン-酢酸ビニル共重合体との混合物等が挙げられる。
Examples of materials that can be used to make the catheter shaft 28 include fluororesins such as polytetrafluoroethylene (PTFE), ethylene-tetrafluoroethylene copolymer (ETFE), and perfluoroalkoxy fluororesin (PFA), olefin resins such as polyethylene and polypropylene, or mixtures of these, polyurethane, polyester, polyamide, polyether nylon resin, and mixtures of olefin resins and ethylene-vinyl acetate copolymers.
カテーテルシャフト28の壁部は、光路26の一部を形成する。カテーテルシャフト28の壁部は、光源部66が発した光L1をカテーテルシャフト28の基端部から先端部35に導く。カテーテルシャフト28のうち少なくとも光路26を形成する部分は、光源部66が発した光L1が透過可能なように透明性を有する。
The wall of the catheter shaft 28 forms part of the light path 26. The wall of the catheter shaft 28 guides the light L1 emitted by the light source unit 66 from the base end of the catheter shaft 28 to the tip end 35. At least the part of the catheter shaft 28 that forms the light path 26 is transparent so that the light L1 emitted by the light source unit 66 can pass through.
カテーテルシャフト28は、その全体が透明性を有してもよい。カテーテルシャフト28のうち少なくとも光路26を形成する部分の構成材料は、例えば、メタクリル樹脂等を含んでもよい。なお、カテーテルシャフト28のうち光路26を形成する部分は、中空であってもよい。
The catheter shaft 28 may be entirely transparent. The material constituting at least the portion of the catheter shaft 28 that forms the optical path 26 may include, for example, methacrylic resin. The portion of the catheter shaft 28 that forms the optical path 26 may be hollow.
図3において、カテーテルハブ30は、中空状(円筒状)に形成されている。カテーテルハブ30の先端部には、カテーテルシャフト28の基端部が固着されている。カテーテルハブ30は、カテーテルシャフト28よりも硬い材料によって構成されることが好ましい。カテーテルハブ30の構成材料は、特に限定されるものではないが、例えば、ポリプロピレン、ポリカーボネート、ポリアミド、ポリサルホン、ポリアリレート、メタクリレート-ブチレン-スチレン共重合体、ポリウレタン、アクリル樹脂、ABS樹脂等の熱可塑性樹脂を好適に用いることができる。カテーテルハブ30の内腔36には、図示しない止血弁が設けられている。
In FIG. 3, the catheter hub 30 is formed in a hollow (cylindrical) shape. The base end of the catheter shaft 28 is fixed to the tip of the catheter hub 30. The catheter hub 30 is preferably made of a material harder than the catheter shaft 28. The material of the catheter hub 30 is not particularly limited, but examples of suitable materials that can be used include thermoplastic resins such as polypropylene, polycarbonate, polyamide, polysulfone, polyarylate, methacrylate-butylene-styrene copolymer, polyurethane, acrylic resin, and ABS resin. A hemostatic valve (not shown) is provided in the inner cavity 36 of the catheter hub 30.
カテーテルハブ30の壁部は、光路26の一部を形成する。カテーテルハブ30の壁部は、光源部66が発した光L1をカテーテルハブ30の基端部から先端部まで導く。カテーテルハブ30のうち少なくとも光路26を形成する部分は、光源部66が発した光L1が透過可能なように透明性を有する。カテーテルハブ30は、その全体が透明性を有してもよい。
The wall of the catheter hub 30 forms part of the light path 26. The wall of the catheter hub 30 guides the light L1 emitted by the light source unit 66 from the base end to the tip end of the catheter hub 30. At least the portion of the catheter hub 30 that forms the light path 26 is transparent so that the light L1 emitted by the light source unit 66 can pass through. The entire catheter hub 30 may be transparent.
カテーテルハブ30のうち少なくとも光路26を形成する部分の構成材料は、例えば、メタクリル樹脂等を含んでもよい。なお、カテーテルハブ30のうち光路26を形成する部分は、中空であってもよい。また、カテーテルハブ30の壁部には、光路26を形成する導光部材(例えば、光ファイバ、アクリル部材、ガラス部材、発光チューブ等)が埋設されてもよい。この場合、導光部材は、カテーテルハブ30の基端部から先端部まで連続して設けられてもよいし、断続して設けられてもよい。
The material constituting at least the portion of the catheter hub 30 that forms the optical path 26 may include, for example, methacrylic resin. The portion of the catheter hub 30 that forms the optical path 26 may be hollow. A light-guiding member (e.g., optical fiber, acrylic member, glass member, light-emitting tube, etc.) that forms the optical path 26 may be embedded in the wall of the catheter hub 30. In this case, the light-guiding member may be provided continuously from the base end to the tip end of the catheter hub 30, or may be provided intermittently.
図2及び図3に示すように、針部材18は、針体38と、針体38の基端部に設けられた針ハブ40とを備える。針体38は、生体部位300(図5及び図7参照)を穿刺可能な剛性を有する管状部材である。針体38は、円管状に形成されている。図3において、針体38は、軸線方向に沿って延在した内腔42を有する。針体38は、血管穿刺デバイス12の初期状態(組立状態)で、カテーテルシャフト28の内腔32及びカテーテルハブ30の内腔36に挿通される。
2 and 3, the needle member 18 comprises a needle body 38 and a needle hub 40 provided at the base end of the needle body 38. The needle body 38 is a tubular member having sufficient rigidity to puncture a biological site 300 (see FIGS. 5 and 7). The needle body 38 is formed in a cylindrical shape. In FIG. 3, the needle body 38 has an inner cavity 42 extending along the axial direction. The needle body 38 is inserted into the inner cavity 32 of the catheter shaft 28 and the inner cavity 36 of the catheter hub 30 in the initial state (assembled state) of the vascular puncture device 12.
針体38は、例えば、ステンレス鋼、アルミニウム、アルミニウム合金、チタン、チタン合金等の金属材料によって構成されている。なお、針体38は、ポリプロピレン(PP)、ポリカーボネート(PC)、ポリエーテルエーテルケトン(PEEK)、液晶ポリマー(LCP)等の樹脂材料によって構成されてもよい。針体38は、カテーテルシャフト28に比べて十分に長く形成され、血管穿刺デバイス12の初期状態においてカテーテルシャフト28の先端開口34から突出している。
The needle body 38 is made of a metal material such as stainless steel, aluminum, an aluminum alloy, titanium, or a titanium alloy. The needle body 38 may also be made of a resin material such as polypropylene (PP), polycarbonate (PC), polyether ether ketone (PEEK), or liquid crystal polymer (LCP). The needle body 38 is formed to be sufficiently long compared to the catheter shaft 28, and protrudes from the tip opening 34 of the catheter shaft 28 in the initial state of the vascular puncture device 12.
針体38の先端部には、針体38の軸線に対して傾斜した刃面44が形成されている。刃面44には、針体38の内腔42に連通する先端開口46が形成されている。
A blade surface 44 is formed at the tip of the needle body 38, which is inclined relative to the axis of the needle body 38. A tip opening 46 that communicates with the inner cavity 42 of the needle body 38 is formed on the blade surface 44.
図3に示すように、針ハブ40は、中空状(筒状)に形成されている。針ハブ40の先端部には、針体38の基端部が挿入される針接続孔48が設けられている。針ハブ40の基端部には、第1係合部50が設けられている。第1係合部50は、針ハブ40の基端面に開口した凹部(孔部)である。
As shown in FIG. 3, the needle hub 40 is formed to be hollow (cylindrical). The tip of the needle hub 40 is provided with a needle connection hole 48 into which the base end of the needle 38 is inserted. The base end of the needle hub 40 is provided with a first engagement portion 50. The first engagement portion 50 is a recess (hole) that opens into the base end surface of the needle hub 40.
針ハブ40は、針体38の内腔42に連通する内腔52を有する。針ハブ40の内腔52には、針体38の内腔42を流通した血液が流入する。針ハブ40の構成材料は、上述したカテーテルハブ30の構成材料と同様のものが挙げられる。
The needle hub 40 has an inner cavity 52 that communicates with the inner cavity 42 of the needle body 38. Blood that has flowed through the inner cavity 42 of the needle body 38 flows into the inner cavity 52 of the needle hub 40. The needle hub 40 can be made of the same materials as those of the catheter hub 30 described above.
針ハブ40の壁部は、光路26の一部を形成する。針ハブ40の壁部は、光源部66が発した光L1を針ハブ40の基端部から先端部まで導く。針ハブ40のうち少なくとも光路26を形成する部分は、光源部66が発した光L1が透過するように透明性を有する。針ハブ40は、その全体が透明性を有してもよい。
The wall of the needle hub 40 forms part of the light path 26. The wall of the needle hub 40 guides the light L1 emitted by the light source unit 66 from the base end to the tip end of the needle hub 40. At least the part of the needle hub 40 that forms the light path 26 is transparent so that the light L1 emitted by the light source unit 66 can pass through. The entire needle hub 40 may be transparent.
針ハブ40のうち少なくとも光路26を形成する部分の構成材料は、例えば、メタクリル樹脂等を含んでもよい。なお、針ハブ40のうち光路26を形成する部分は、中空であってもよい。また、針ハブ40の壁部には、光路26を形成する導光部材(例えば、光ファイバ、アクリル部材、ガラス部材、発光チューブ等)が埋設されてもよい。この場合、導光部材は、針ハブ40の基端部から先端部まで連続して設けられてもよいし、断続して設けられてもよい。
The material of at least the portion of the needle hub 40 that forms the light path 26 may include, for example, methacrylic resin. The portion of the needle hub 40 that forms the light path 26 may be hollow. A light-guiding member (e.g., optical fiber, acrylic member, glass member, light-emitting tube, etc.) that forms the light path 26 may be embedded in the wall of the needle hub 40. In this case, the light-guiding member may be provided continuously from the base end to the tip end of the needle hub 40, or may be provided intermittently.
血液流通阻止部20は、支持部54と、支持部54に支持されたフィルター56とを有する。支持部54は、中空に形成されている。支持部54は、支持部54内に配置されたフィルター56を支持する。支持部54の先端部には、第1係合部50に係合する第2係合部58が設けられている。第2係合部58は、凹部である第1係合部50に嵌合する凸部である。ただし、第1係合部50が凸部であり、第2係合部58が凹部であってもよい。支持部54は、針ハブ40に対して固定されている。支持部54は、針ハブ40に対して一体成形されてもよい。
The blood flow blocking section 20 has a support section 54 and a filter 56 supported by the support section 54. The support section 54 is formed hollow. The support section 54 supports the filter 56 arranged inside the support section 54. A second engagement section 58 that engages with the first engagement section 50 is provided at the tip of the support section 54. The second engagement section 58 is a convex section that fits into the first engagement section 50, which is a concave section. However, the first engagement section 50 may be a convex section and the second engagement section 58 may be a concave section. The support section 54 is fixed to the needle hub 40. The support section 54 may be molded integrally with the needle hub 40.
支持部54は、針ハブ40の内腔52に連通する血液流路60を有する。血液流路60には、針ハブ40の内腔52の血液が流通する。針ハブ40の内腔52と血液流路60とは、針体38の先端開口46から流入した血液が導かれるフラッシュバック確認用の血液流入部62を形成する。血液流路60は、針体38の軸線方向に沿って延在している。血液流路60は、針体38の軸線の延長線上に位置する。
The support portion 54 has a blood flow path 60 that communicates with the inner cavity 52 of the needle hub 40. Blood in the inner cavity 52 of the needle hub 40 flows through the blood flow path 60. The inner cavity 52 of the needle hub 40 and the blood flow path 60 form a blood inlet portion 62 for checking flashback, into which blood that has flowed in from the tip opening 46 of the needle body 38 is guided. The blood flow path 60 extends along the axial direction of the needle body 38. The blood flow path 60 is located on an extension of the axis of the needle body 38.
支持部54のうちフィルター56よりも基端方向には、光源ユニット22を装着するための装着部64が設けられている。装着部64は、支持部54の基端面に開口する凹部(孔部)である。装着部64は、針体38の軸線上に位置している。
A mounting portion 64 for mounting the light source unit 22 is provided on the support portion 54 in the proximal direction from the filter 56. The mounting portion 64 is a recess (hole) that opens into the proximal end surface of the support portion 54. The mounting portion 64 is located on the axis of the needle body 38.
支持部54の壁部は、光路26の一部を形成する。支持部54の壁部は、光源部66が発した光L1を支持部54の基端部から先端部まで導く。支持部54のうち少なくとも光路26を形成する部分は、光源部66が発した光L1が透過するように透明性を有する。支持部54は、その全体が透明性を有してもよい。
The wall of the support portion 54 forms part of the light path 26. The wall of the support portion 54 guides the light L1 emitted by the light source portion 66 from the base end to the tip end of the support portion 54. At least the portion of the support portion 54 that forms the light path 26 is transparent so that the light L1 emitted by the light source portion 66 can pass through. The entire support portion 54 may be transparent.
支持部54のうち少なくとも光路26を形成する部分の構成材料は、例えば、メタクリル樹脂等を含んでもよい。なお、支持部54のうち光路26を形成する部分は、中空であってもよい。また、支持部54の壁部には、光路26を形成する導光部材(例えば、光ファイバ、アクリル部材、ガラス部材、発光チューブ等)が埋設されてもよい。この場合、導光部材は、支持部54の基端部から先端部まで連続して設けられてもよいし、断続して設けられてもよい。
The constituent material of at least the portion of the support 54 that forms the light path 26 may include, for example, methacrylic resin. The portion of the support 54 that forms the light path 26 may be hollow. A light-guiding member (e.g., optical fiber, acrylic member, glass member, light-emitting tube, etc.) that forms the light path 26 may be embedded in the wall of the support 54. In this case, the light-guiding member may be provided continuously from the base end to the tip end of the support 54, or may be provided intermittently.
フィルター56は、血液流路60を基端方向から塞ぐように配置されている。フィルター56は、空気の流通を許可する一方で血液の流通を阻止する。すなわち、フィルター56は、血液流路60を流通する血液が装着部64に流れることを阻止する。フィルター56は、光源部66が発した光L1を透過する材料によって構成されるのが好ましい。
The filter 56 is positioned so as to block the blood flow path 60 from the proximal direction. The filter 56 allows air to flow while blocking blood flow. In other words, the filter 56 blocks blood flowing through the blood flow path 60 from flowing into the attachment part 64. The filter 56 is preferably made of a material that transmits the light L1 emitted by the light source part 66.
支持部54のうちフィルター56よりも基端方向には、血液流入部62に血液が円滑に流入されるように図示しない1つ又は複数の空気抜き孔が形成されている。なお、血液流入部62内の空気を外部に排出するための1つ又は複数の空気抜き孔は、針ハブ40に設けられてもよい。この場合、当該空気抜き孔に血液の流出を防止するためのフィルター56が設けられる。
One or more air vent holes (not shown) are formed in the support section 54 proximal to the filter 56 to allow blood to flow smoothly into the blood inlet section 62. Note that one or more air vent holes for discharging air from within the blood inlet section 62 to the outside may be provided in the needle hub 40. In this case, a filter 56 is provided in the air vent hole to prevent blood from flowing out.
光源ユニット22は、装着部64に着脱可能に形成されている。光源ユニット22を装着部64に装着した状態で、光源ユニット22の外面は、血液流通阻止部20の外面と面一になっている。換言すれば、光源ユニット22の外面には、光源ユニット22を装着部64に装着した状態で血液流通阻止部20の外面よりも外方に突出するような凸部が設けられていない。この場合、針体38を血管302に穿刺する時に光源ユニット22が生体に当たることを抑制できる。なお、光源ユニット22を装着部64に装着した状態で、光源ユニット22の外面は、血液流通阻止部20の外面よりも径方向内方(内側)に位置してもよい。
The light source unit 22 is formed so as to be detachable from the mounting portion 64. When the light source unit 22 is mounted on the mounting portion 64, the outer surface of the light source unit 22 is flush with the outer surface of the blood flow blocking portion 20. In other words, the outer surface of the light source unit 22 does not have a protrusion that protrudes outward beyond the outer surface of the blood flow blocking portion 20 when the light source unit 22 is mounted on the mounting portion 64. In this case, it is possible to prevent the light source unit 22 from hitting the living body when the needle body 38 is inserted into the blood vessel 302. Note that when the light source unit 22 is mounted on the mounting portion 64, the outer surface of the light source unit 22 may be located radially inward (inner) than the outer surface of the blood flow blocking portion 20.
光源ユニット22は、光源部66、電力供給部68及びハウジング70を有する。光源部66は、ハウジング70に収納されている。光源部66としては、例えば、LED、ランプ(例えば、ハロゲンランプ)、レーザー照射ユニット(例えば、レーザーダイオード)等が用いられる。
The light source unit 22 has a light source section 66, a power supply section 68, and a housing 70. The light source section 66 is housed in the housing 70. As the light source section 66, for example, an LED, a lamp (e.g., a halogen lamp), a laser irradiation unit (e.g., a laser diode), etc. can be used.
光源部66は、血液のヘモグロビンに吸収され易く、皮下組織を透過し易い波長領域の光L1を発する。具体的に、光源部66は、可視光及び近赤外光の少なくともいずれかを発する。可視光の波長は、600nm以上700nm未満が好ましい。近赤外光の波長は、700nm以上2500nm以下であり、700nm以上1400nm以下が好ましく、780nm以上940nm以下がより好ましい。
The light source unit 66 emits light L1 in a wavelength range that is easily absorbed by hemoglobin in blood and easily transmits through subcutaneous tissue. Specifically, the light source unit 66 emits at least one of visible light and near-infrared light. The wavelength of visible light is preferably 600 nm or more and less than 700 nm. The wavelength of near-infrared light is 700 nm or more and 2500 nm or less, preferably 700 nm or more and 1400 nm or less, and more preferably 780 nm or more and 940 nm or less.
光源部66が発する光L1は、600nm以上2500nm以下のピーク波長を有する。光源部66は、複数波長の光L1を同時に発してもよい。つまり、光源部66は、例えば、600nmの可視光と850nmの近赤外光とを同時に発してもよい。光源部66は、当該光L1の輝度を調整可能である。光源部66は、連続して点灯してもよいし、点滅してもよい。
The light L1 emitted by the light source unit 66 has a peak wavelength of 600 nm or more and 2500 nm or less. The light source unit 66 may simultaneously emit light L1 of multiple wavelengths. That is, the light source unit 66 may simultaneously emit, for example, visible light of 600 nm and near-infrared light of 850 nm. The light source unit 66 is capable of adjusting the brightness of the light L1. The light source unit 66 may be lit continuously or may flash.
電力供給部68は、ハウジング70に設けられている。電力供給部68は、電力を光源部66に供給する。電力供給部68は、例えば、電池を含む。電池としては、一次電池、二次電池、太陽電池等が挙げられる。電力供給部68は、無線給電装置を含んでもよいし、配線用差込接続器(コンセント)に接続可能な差込プラグを含んでもよい。電力供給部68は、ハウジング70の基端部に設けられている。電力供給部68は、ハウジング70内に収容されてもよい。
The power supply unit 68 is provided in the housing 70. The power supply unit 68 supplies power to the light source unit 66. The power supply unit 68 includes, for example, a battery. Examples of the battery include a primary battery, a secondary battery, a solar cell, etc. The power supply unit 68 may include a wireless power supply device, or may include a plug that can be connected to a wiring socket connector (outlet). The power supply unit 68 is provided at the base end of the housing 70. The power supply unit 68 may be housed within the housing 70.
ハウジング70は、例えば、筒状(例えば、円筒状)に形成されている。ハウジング70は、光源部66の収容空間72が形成されたハウジング本体74と、ハウジング本体74から突出して装着部64に着脱可能な接続部76とを有する。光源部66が発した光L1が外部に漏れないように、ハウジング本体74の一部は、当該光L1が透過しない材料で形成されている。或いは、ハウジング本体74の一部(外周面又は内周面)は、光L1が透過しない材料によってコーティングされている。
The housing 70 is formed, for example, in a tubular (e.g., cylindrical) shape. The housing 70 has a housing main body 74 in which an accommodating space 72 for the light source unit 66 is formed, and a connecting portion 76 that protrudes from the housing main body 74 and is detachable from the mounting portion 64. To prevent the light L1 emitted by the light source unit 66 from leaking to the outside, a portion of the housing main body 74 is formed from a material that is opaque to the light L1. Alternatively, a portion of the housing main body 74 (the outer peripheral surface or the inner peripheral surface) is coated with a material that is opaque to the light L1.
接続部76は、凹部である装着部64に嵌合可能な凸部である。接続部76には、収容空間72に連通する光導出孔78が形成されている。光導出孔78は、接続部76の先端面に開口している。接続部76は、中実に形成されてもよい。この場合、接続部76は、光源部66が発した光L1が透過するように透明性を有する。
The connection part 76 is a convex part that can be fitted into the mounting part 64, which is a concave part. A light guide hole 78 that communicates with the storage space 72 is formed in the connection part 76. The light guide hole 78 opens at the tip surface of the connection part 76. The connection part 76 may be formed solid. In this case, the connection part 76 has transparency so that the light L1 emitted by the light source part 66 can pass through.
接続部76及び装着部64は、アルコール清拭し易いように凹凸を有しない平滑面を有することが好ましい。接続部76が装着部64に装着された状態で、光源部66は、針体38の軸線の延長線上に位置する。接続部76が装着部64に装着された状態で、光源部66は、針体38の先端方向に向かって光L1を発する。
The connection part 76 and the attachment part 64 preferably have smooth surfaces without any irregularities so that they can be easily wiped with alcohol. When the connection part 76 is attached to the attachment part 64, the light source part 66 is located on an extension of the axis of the needle body 38. When the connection part 76 is attached to the attachment part 64, the light source part 66 emits light L1 toward the tip of the needle body 38.
血液流通阻止部20及び光源ユニット22の装着構造は、装着部64が凸部であり接続部76が凹部(孔部)であってもよい。また、当該装着構造は、凹凸による嵌合構造に限定されず、爪係合構造、磁石による吸着構造、面ファスナーによる係合構造、ねじによる螺合構造等であってもよい。
The mounting structure of the blood flow blocking portion 20 and the light source unit 22 may be such that the mounting portion 64 is a convex portion and the connection portion 76 is a concave portion (hole portion). In addition, the mounting structure is not limited to a fitting structure using convex and concave portions, but may be a claw engagement structure, a magnetic attraction structure, a hook-and-loop fastener engagement structure, a screw-threaded structure, etc.
血管穿刺デバイス12は、光源部66が発した光L1をカテーテルシャフト28の先端部35に導く時に当該光L1が外部に漏れることを抑制するための光透過抑制部80を有する。光透過抑制部80は、カテーテルシャフト28、カテーテルハブ30、針ハブ40及び血液流通阻止部20の各々の外表面に設けられている。
The vascular puncture device 12 has a light transmission suppression section 80 for suppressing leakage of light L1 emitted by the light source section 66 to the outside when the light L1 is guided to the tip section 35 of the catheter shaft 28. The light transmission suppression section 80 is provided on the outer surface of each of the catheter shaft 28, the catheter hub 30, the needle hub 40, and the blood flow blocking section 20.
光透過抑制部80は、カテーテルシャフト28の先端から所定長だけ基端方向にずれた位置からカテーテルハブ30の先端の位置まで設けられている。換言すれば、光透過抑制部80は、カテーテルシャフト28の先端部35に設けられていない。すなわち、光源部66が発した光L1は、カテーテルシャフト28の先端部35から外部に導出する。カテーテルシャフト28の先端部35は、光源部66が発した光L1が照射されることによって近赤外光を発光する蛍光材料を含んでもよい。また、カテーテルシャフト28の先端部35は、近赤外光を発する燐光材料を含んでもよい。カテーテルシャフト28の先端部35は、近赤外光を可視光に変換可能なフィルムであってもよい。この場合、カテーテルハブ30及び針ハブ40から可視光を発光させることなく先端部35のみを発光させることができるため、先端部35を視認し易くなる。
The light transmission suppression section 80 is provided from a position shifted from the tip of the catheter shaft 28 in the proximal direction by a predetermined length to the tip of the catheter hub 30. In other words, the light transmission suppression section 80 is not provided at the tip 35 of the catheter shaft 28. That is, the light L1 emitted by the light source section 66 is guided to the outside from the tip 35 of the catheter shaft 28. The tip 35 of the catheter shaft 28 may contain a fluorescent material that emits near-infrared light when irradiated with the light L1 emitted by the light source section 66. The tip 35 of the catheter shaft 28 may also contain a phosphorescent material that emits near-infrared light. The tip 35 of the catheter shaft 28 may be a film that can convert near-infrared light into visible light. In this case, only the tip 35 can be made to emit light without the catheter hub 30 and the needle hub 40 emitting visible light, making it easier to visually recognize the tip 35.
光透過抑制部80は、例えば、カテーテルハブ30、針ハブ40及び支持部54の各々の外周面に設けられている。なお、血液流入部62を外部から視認できるように、針ハブ40及び支持部54は、外面に光透過抑制部80が設けられていない部分を有する。
The light transmission suppression section 80 is provided, for example, on the outer peripheral surfaces of the catheter hub 30, the needle hub 40, and the support section 54. Note that the needle hub 40 and the support section 54 have portions on their outer surfaces where the light transmission suppression section 80 is not provided, so that the blood inlet section 62 can be seen from the outside.
光透過抑制部80は、例えば、カーボンブラック等の光不透過材料を対象表面に塗装することによって形成される。また、光透過抑制部80は、例えば、対象表面に金属膜を蒸着又はコーティングすることにより形成してもよい。
The light transmission suppression section 80 is formed, for example, by painting a light-opaque material such as carbon black onto the target surface. The light transmission suppression section 80 may also be formed, for example, by evaporating or coating a metal film onto the target surface.
図1に示すように、可視化装置14は、照射部82、受光部84及び画像表示部86を備える。照射部82は、血管穿刺デバイス12が穿刺された生体部位300(可視化対象物)に光L2を照射する。照射部82は、光L2を発する照射部本体88を有する。照射部本体88は、光L2として近赤外光を発する。照射部本体88が発する近赤外光の波長は、700nm以上2500nm以下であり、700nm以上1400nm以下が好ましく、780nm以上940nm以下がより好ましい。なお、光L1の波長と光L2の波長とは、互いに同じであってもよいし、異なっていてもよい。
As shown in FIG. 1, the visualization device 14 includes an irradiation unit 82, a light receiving unit 84, and an image display unit 86. The irradiation unit 82 irradiates light L2 to a biological site 300 (object to be visualized) punctured by the vascular puncture device 12. The irradiation unit 82 has an irradiation unit main body 88 that emits light L2. The irradiation unit main body 88 emits near-infrared light as light L2. The wavelength of the near-infrared light emitted by the irradiation unit main body 88 is 700 nm or more and 2500 nm or less, preferably 700 nm or more and 1400 nm or less, and more preferably 780 nm or more and 940 nm or less. The wavelengths of light L1 and light L2 may be the same or different.
受光部84は、生体部位300を挟んで照射部82とは反対側に配置される。換言すれば、照射部82と受光部84とは、生体部位300を挟んで互いに対向するように配置されている。受光部84は、光源部66が発した光L1と照射部82が発した光L2とを受光するためのカメラ(撮像部)である。受光部84は、例えば、近赤外光用のCCDカメラ等が用いられる。また、受光部84は、近赤外光を可視光に変換可能なフィルムであってもよい。
The light receiving unit 84 is disposed on the opposite side of the body part 300 from the irradiation unit 82. In other words, the irradiation unit 82 and the light receiving unit 84 are disposed so as to face each other with the body part 300 in between. The light receiving unit 84 is a camera (imaging unit) for receiving the light L1 emitted by the light source unit 66 and the light L2 emitted by the irradiation unit 82. For example, a CCD camera for near-infrared light is used as the light receiving unit 84. The light receiving unit 84 may also be a film capable of converting near-infrared light into visible light.
画像表示部86は、受光部84が受光した光L1、L2に基づいて作成された画像(受光画像90)を表示する。画像表示部86は、人が着脱可能なゴーグルであってもよいし、定置型のディスプレイであってもよいし、プロジェクターであってもよい。
The image display unit 86 displays an image (received light image 90) created based on the light L1 and L2 received by the light receiving unit 84. The image display unit 86 may be goggles that can be worn or removed by a person, a fixed display, or a projector.
可視化装置14において、照射部82は、生体部位300に対して受光部84が位置する側に配置されてもよい。この場合、受光部84は、照射部82が発した光L2のうち生体部位300で反射した光(反射光)を受光する。また、可視化装置14では、照射部82は、生体部位300を挟んで受光部84とは反対側と生体部位300に対して受光部84が位置する側との両方に配置されてもよい。この場合、各照射部82が発した光L2のうち生体部位300を透過した光(透過光)と生体部位300で反射した光(反射光)の両方が受光部84で受光される。
In the visualization device 14, the irradiation unit 82 may be arranged on the side of the biological part 300 where the light receiving unit 84 is located. In this case, the light receiving unit 84 receives the light L2 emitted by the irradiation unit 82 that is reflected by the biological part 300 (reflected light). In addition, in the visualization device 14, the irradiation unit 82 may be arranged on both the opposite side of the biological part 300 to the light receiving unit 84 and the side of the biological part 300 where the light receiving unit 84 is located. In this case, both the light L2 emitted by each irradiation unit 82 that is transmitted through the biological part 300 (transmitted light) and the light reflected by the biological part 300 (reflected light) are received by the light receiving unit 84.
次に、血管穿刺デバイス12の血管302への穿刺手技の一例について説明する。
Next, an example of a procedure for puncturing a blood vessel 302 using the blood vessel puncture device 12 will be described.
図3に示すように、血管穿刺デバイス12の初期状態で、刃面44は、上方に向いた状態でカテーテルシャフト28の先端開口34から先端方向に突出している。なお、光源ユニット22は、血液流通阻止部20に装着されていない。また、ここでは、光源部66は、近赤外光を含む光L1を発する場合を説明する。
As shown in FIG. 3, in the initial state of the vascular puncture device 12, the blade surface 44 faces upward and protrudes from the tip opening 34 of the catheter shaft 28 toward the tip. The light source unit 22 is not attached to the blood flow blocking section 20. Here, the case where the light source section 66 emits light L1 including near-infrared light will be described.
まず、ユーザは、患者の穿刺対象である血管302に基づいて光源ユニット22の必要性を判断する。具体的に、ユーザは、穿刺対象である血管302が外部から把握し易く(血管確保の判断が簡単であり)光源ユニット22が不要であると判断した場合には、光源ユニット22を血液流通阻止部20に装着することなく、血管302への線状部24(針体38及びカテーテルシャフト28)の穿刺操作を行う。
First, the user determines whether the light source unit 22 is necessary based on the patient's blood vessel 302 to be punctured. Specifically, if the user determines that the blood vessel 302 to be punctured is easy to grasp from the outside (easy to determine whether the blood vessel is secured) and the light source unit 22 is unnecessary, the user performs the puncture operation of the linear portion 24 (needle body 38 and catheter shaft 28) into the blood vessel 302 without attaching the light source unit 22 to the blood flow blocking portion 20.
一方、ユーザは、穿刺対象である血管302が外部から把握し難く(血管確保の判断が難しく)光源ユニット22が必要であると判断した場合には、図4に示すように、光源ユニット22の接続部76を血液流通阻止部20の装着部64に装着する。
On the other hand, if the user determines that the blood vessel 302 to be punctured is difficult to grasp from the outside (difficult to determine whether the blood vessel is secured) and therefore the light source unit 22 is necessary, the user attaches the connection portion 76 of the light source unit 22 to the attachment portion 64 of the blood flow blocking portion 20, as shown in FIG. 4.
続いて、ユーザは、可視化装置14をセッティングする。具体的に、図5に示すように、生体部位300(例えば、人体の前腕)の下方に照射部82を配置すると共に生体部位300の上方に受光部84を配置する。そして、照射部82から生体部位300に光L2を照射すると共に生体部位300(血管302よりも手前の位置)に線状部24の先端部を穿刺する。
Then, the user sets up the visualization device 14. Specifically, as shown in FIG. 5, the irradiation unit 82 is placed below the biological part 300 (e.g., the forearm of a human body) and the light receiving unit 84 is placed above the biological part 300. Then, the irradiation unit 82 irradiates the biological part 300 with light L2 and the tip of the linear part 24 is inserted into the biological part 300 (at a position closer to the blood vessel 302).
そうすると、照射部82が発した光L2は、生体部位300の血管302以外の生体組織304(例えば、皮膚組織や筋組織)を散乱しながら透過し、透過した光L2(透過光)が受光部84で受光される。この際、血管302内を流れる血液のヘモグロビンは、光L2を吸収する。また、光L2は、針体38を透過しない。
The light L2 emitted by the irradiation unit 82 then passes through the biological tissue 304 (e.g., skin tissue and muscle tissue) other than the blood vessels 302 of the biological part 300 while being scattered, and the transmitted light L2 (transmitted light) is received by the light receiving unit 84. At this time, the hemoglobin in the blood flowing through the blood vessels 302 absorbs the light L2. Furthermore, the light L2 does not pass through the needle body 38.
光源部66が発した光L1は、光路26(光導出孔78、支持部54、針ハブ40、カテーテルハブ30及びカテーテルシャフト28)を介してカテーテルシャフト28の先端部35から導出する。カテーテルシャフト28の先端部35から導出した光L1は、生体部位300の生体組織304(例えば、皮膚組織や筋組織)を散乱しながら透過し、透過した光L1(透過光)が受光部84で受光される。
Light L1 emitted by the light source unit 66 is guided out from the tip 35 of the catheter shaft 28 via the optical path 26 (light guide hole 78, support unit 54, needle hub 40, catheter hub 30, and catheter shaft 28). Light L1 guided out from the tip 35 of the catheter shaft 28 passes through the biological tissue 304 (e.g., skin tissue or muscle tissue) of the biological part 300 while being scattered, and the transmitted light L1 (transmitted light) is received by the light receiving unit 84.
これにより、図6に示すように、画像表示部86には、受光部84で受光された光L1、L2に基づいて作成された受光画像90が表示される。受光画像90には、例えば、生体組織304、血管302、線状部24の先端部が表示される。
As a result, as shown in FIG. 6, a received light image 90 created based on the light L1 and L2 received by the light receiving unit 84 is displayed on the image display unit 86. For example, the biological tissue 304, blood vessels 302, and the tip of the linear portion 24 are displayed on the received light image 90.
具体的に、受光画像90では、カテーテルシャフト28の先端部35(光L1が導出している部分)が最も明るく(白色に)表示され、生体組織304がカテーテルシャフト28の先端部35よりも暗く表示される。また、受光画像90において、血管302及び針体38は、生体組織304よりも暗く表示される。なお、針体38が血管302に穿刺されていない状態で、針体38の輝度は、血管302の輝度以上である。これにより、ユーザは、受光画像90中の血管302とカテーテルシャフト28の先端部35とを容易且つ明確に区別することができる。
Specifically, in the received light image 90, the tip 35 of the catheter shaft 28 (the portion from which the light L1 is emitted) is displayed brightest (white), and the biological tissue 304 is displayed darker than the tip 35 of the catheter shaft 28. Also, in the received light image 90, the blood vessel 302 and the needle body 38 are displayed darker than the biological tissue 304. Note that when the needle body 38 is not inserted into the blood vessel 302, the brightness of the needle body 38 is equal to or greater than the brightness of the blood vessel 302. This allows the user to easily and clearly distinguish between the blood vessel 302 and the tip 35 of the catheter shaft 28 in the received light image 90.
続いて、図7に示すように、針体38の先端開口46が血管302内に挿入されると、血管302内の血液は、針体38の先端開口46から針体38の内腔42を通り血液流入部62内に導かれる。この時、針体38の内腔42及び血液流入部62内の空気は、フィルター56を通り血液流通阻止部20の図示しない空気抜き孔から排出される。そのため、血液は、針ハブ40の血液流入部62内に円滑に導かれる。そして、ユーザは、血液流入部62に導かれた血液を視認することにより、針体38の先端開口46が血管302内に挿入されたこと(針体38の血管確保)を知ることができる。
Next, as shown in FIG. 7, when the tip opening 46 of the needle body 38 is inserted into the blood vessel 302, blood in the blood vessel 302 is guided from the tip opening 46 of the needle body 38 through the lumen 42 of the needle body 38 into the blood inlet section 62. At this time, air in the lumen 42 of the needle body 38 and the blood inlet section 62 passes through the filter 56 and is discharged from an air vent hole (not shown) of the blood flow blocking section 20. Therefore, the blood is smoothly guided into the blood inlet section 62 of the needle hub 40. Then, by visually checking the blood guided to the blood inlet section 62, the user can know that the tip opening 46 of the needle body 38 has been inserted into the blood vessel 302 (the blood vessel is secured by the needle body 38).
この時、血液流入部62内の血液の基端方向の流れはフィルター56によって阻止される。よって、血液流入部62内の血液が光源ユニット22に接触することはない。
At this time, the flow of blood in the blood inlet 62 toward the proximal end is blocked by the filter 56. Therefore, the blood in the blood inlet 62 does not come into contact with the light source unit 22.
また、カテーテルシャフト28の先端部35が血管302内に挿入されると、光源部66が発した光L1は、血液のヘモグロビンによって吸収される。そのため、光L1は、受光部84まで届かないか、受光部84まで届いたとしても強度が大きく低下する。
In addition, when the tip 35 of the catheter shaft 28 is inserted into the blood vessel 302, the light L1 emitted by the light source 66 is absorbed by the hemoglobin in the blood. As a result, the light L1 does not reach the light receiving unit 84, or even if it does reach the light receiving unit 84, its intensity is greatly reduced.
よって、図8に示すように、受光画像90において、カテーテルシャフト28の先端部35の見え方が変化する(カテーテルシャフト28の先端部35が暗くなる)。換言すれば、受光画像90において、カテーテルシャフト28の先端部35の輝度は、血管302の輝度以下になる。また、受光画像90において、針体38の輝度も、血管302の輝度以下である。そのため、ユーザは、カテーテルシャフト28の先端部35が血管302内に挿入されたこと(カテーテルシャフト28の血管確保)を受光画像90により簡単且つ速やかに知ることができる。
Therefore, as shown in FIG. 8, the appearance of the tip 35 of the catheter shaft 28 changes in the received light image 90 (the tip 35 of the catheter shaft 28 becomes darker). In other words, in the received light image 90, the brightness of the tip 35 of the catheter shaft 28 becomes equal to or lower than the brightness of the blood vessel 302. Also, in the received light image 90, the brightness of the needle body 38 is equal to or lower than the brightness of the blood vessel 302. Therefore, the user can easily and quickly know from the received light image 90 that the tip 35 of the catheter shaft 28 has been inserted into the blood vessel 302 (the catheter shaft 28 has secured the blood vessel).
その後、図9に示すように、ユーザは、カテーテルシャフト28の先端部35を血管302内に留置した状態で針部材18をカテーテル部材16から抜去し、カテーテルシャフト28の内腔32を介して血管302内に薬液を投与する。
Then, as shown in FIG. 9, the user removes the needle member 18 from the catheter member 16 while leaving the tip 35 of the catheter shaft 28 in the blood vessel 302, and administers the medicinal liquid into the blood vessel 302 via the lumen 32 of the catheter shaft 28.
また、図10に示すように、血液流通阻止部20から光源ユニット22を取り外す。血液流通阻止部20から取り外された光源ユニット22は、再利用される。なお、使用済みの針部材18と針ハブ40に固定された血液流通阻止部20とは、一緒に廃棄される。
Furthermore, as shown in FIG. 10, the light source unit 22 is removed from the blood flow blocking portion 20. The light source unit 22 removed from the blood flow blocking portion 20 is reused. The used needle member 18 and the blood flow blocking portion 20 fixed to the needle hub 40 are discarded together.
ところで、本実施形態において、光源部66が可視光のみを発する場合には、カテーテルシャフト28の血管確保前の状態で、ユーザは、カテーテルシャフト28の先端部35から導出された光L1を認識できる。一方、カテーテルシャフト28の血管確保の状態で、当該光L1が血液中のヘモグロビンに吸収されるため、ユーザは、カテーテルシャフト28の先端部35から導出された光L1を認識できなくなる。従って、光源部66が可視光のみを発する場合であっても、光源部66が発した光L1に基づいて線状部24の血管確保を簡単且つ速やかに知ることができる。
In this embodiment, when the light source unit 66 emits only visible light, the user can recognize the light L1 emitted from the tip 35 of the catheter shaft 28 before the catheter shaft 28 secures the blood vessel. On the other hand, when the catheter shaft 28 secures the blood vessel, the light L1 is absorbed by hemoglobin in the blood, and the user cannot recognize the light L1 emitted from the tip 35 of the catheter shaft 28. Therefore, even when the light source unit 66 emits only visible light, the user can easily and quickly know that the linear portion 24 has secured the blood vessel based on the light L1 emitted by the light source unit 66.
本実施形態は、以下の効果を奏する。
This embodiment provides the following advantages:
本実施形態によれば、血液流通阻止部20の装着部64に光源ユニット22が着脱可能であるため、状況に応じて光源ユニット22を使用するか否かを選択できる。また、光源ユニット22を使用する場合、光源部66が発した光L1は、光路26を介してカテーテルシャフト28の先端部35に導かれる。
In this embodiment, the light source unit 22 is detachable from the attachment portion 64 of the blood flow blocking portion 20, so it is possible to select whether or not to use the light source unit 22 depending on the situation. Furthermore, when the light source unit 22 is used, the light L1 emitted by the light source portion 66 is guided to the tip portion 35 of the catheter shaft 28 via the optical path 26.
カテーテルシャフト28の血管確保前の状態では、カテーテルシャフト28の先端部35から導出された光L1は、生体組織304(血管302以外の皮下組織等)を透過して生体部位300の外側に導かれる。一方、カテーテルシャフト28の血管確保の状態では、カテーテルシャフト28の先端部35から導出された光L1は、血液に吸収されたり血液を透過する時に減衰したりする。つまり、カテーテルシャフト28の血管確保の前後で、生体部位300の外側で受光又は視認できる光L1の強度が変化するため、光源部66が発した光L1に基づいてカテーテルシャフト28(線状部24)の血管確保を簡単且つ速やかに知ることができる。
Before the catheter shaft 28 secures the blood vessel, the light L1 emitted from the tip 35 of the catheter shaft 28 passes through the biological tissue 304 (subcutaneous tissue other than the blood vessel 302, etc.) and is guided to the outside of the biological part 300. On the other hand, when the catheter shaft 28 secures the blood vessel, the light L1 emitted from the tip 35 of the catheter shaft 28 is absorbed by the blood or attenuated as it passes through the blood. In other words, the intensity of the light L1 that can be received or seen outside the biological part 300 changes before and after the catheter shaft 28 secures the blood vessel, so that it is possible to easily and quickly know whether the catheter shaft 28 (linear part 24) has secured the blood vessel based on the light L1 emitted by the light source unit 66.
さらに、針体38の血管確保により血液が血液流入部62に流入するため、ユーザは、血液流入部62への血液の流入を視認することにより針体38の血管確保を精度よく知ることができる。この時、装着部64への血液の流通は血液流通阻止部20によって阻止されている。そのため、装着部64に装着されている光源ユニット22が血液に触れることはない。従って、光源ユニット22を再利用できる。
Furthermore, since blood flows into the blood inlet section 62 as the needle body 38 secures the blood vessel, the user can accurately know whether the needle body 38 has secured the blood vessel by visually checking the blood flow into the blood inlet section 62. At this time, the blood flow to the attachment section 64 is blocked by the blood flow blocking section 20. Therefore, the light source unit 22 attached to the attachment section 64 does not come into contact with blood. Therefore, the light source unit 22 can be reused.
光源ユニット22が装着部64に装着された状態で、光源部66は、線状部24の先端方向に向かって光L1を発する。
When the light source unit 22 is attached to the attachment portion 64, the light source portion 66 emits light L1 toward the tip of the linear portion 24.
このような構成によれば、光源部66が発した光L1を線状部24の先端部(カテーテルシャフト28の先端部35)に簡単に導くことができる。
With this configuration, the light L1 emitted by the light source unit 66 can be easily guided to the tip of the linear portion 24 (the tip 35 of the catheter shaft 28).
光源ユニット22は、光源部66を収容するハウジング70を有し、ハウジング70は、装着部64に着脱可能な接続部76を有する。
The light source unit 22 has a housing 70 that houses the light source section 66, and the housing 70 has a connection section 76 that can be attached and detached to the attachment section 64.
このような構成によれば、光源部66をハウジング70によって保護できる。
With this configuration, the light source unit 66 can be protected by the housing 70.
血液流通阻止部20は、針ハブ40の基端部に固定されている。
The blood flow blocking section 20 is fixed to the base end of the needle hub 40.
このような構成によれば、針ハブ40と血液流通阻止部20との間からの血液の漏れを抑制できる。
This configuration can prevent blood from leaking between the needle hub 40 and the blood flow blocking portion 20.
血液流通阻止部20は、血液流入部62から装着部64への血液の流通を阻止するフィルター56と、フィルター56を支持する支持部54と、を備える。装着部64は、支持部54の基端部に設けられている。
The blood flow blocking section 20 includes a filter 56 that blocks blood flow from the blood inlet section 62 to the attachment section 64, and a support section 54 that supports the filter 56. The attachment section 64 is provided at the base end of the support section 54.
このような構成によれば、フィルター56によって血液流入部62から装着部64への血液の流通を効果的に抑制できる。
With this configuration, the filter 56 can effectively suppress the flow of blood from the blood inlet portion 62 to the attachment portion 64.
光源部66は、近赤外光を含む光L1を発する。
The light source unit 66 emits light L1 that includes near-infrared light.
このような構成によれば、血管確保の前後で光源部66が発してカテーテルシャフト28の先端部35から導出された光L1の見え方を効果的に変化させることができる。
This configuration effectively changes the appearance of the light L1 emitted by the light source unit 66 and guided out from the tip 35 of the catheter shaft 28 before and after the blood vessel is secured.
光路26は、血液流通阻止部20の壁部、針ハブ40の壁部、カテーテルハブ30の壁部及びカテーテルシャフト28の壁部に設けられている。光源部66が発した光L1は、カテーテルシャフト28の先端部35から外部に導出される。
The light path 26 is provided in the wall of the blood flow blocking section 20, the wall of the needle hub 40, the wall of the catheter hub 30, and the wall of the catheter shaft 28. The light L1 emitted by the light source 66 is guided to the outside from the tip 35 of the catheter shaft 28.
このような構成によれば、光源部66が発した光L1に基づいてカテーテルシャフト28の血管確保を知ることができる。また、簡単な構成により、光源部66が発した光L1をカテーテルシャフト28の先端部35に導くことができる。
With this configuration, it is possible to know whether the catheter shaft 28 has secured a blood vessel based on the light L1 emitted by the light source unit 66. In addition, with a simple configuration, the light L1 emitted by the light source unit 66 can be guided to the tip 35 of the catheter shaft 28.
血液流通阻止部20の壁部、針ハブ40の壁部、カテーテルハブ30の壁部及びカテーテルシャフト28の壁部の各々の外周面には、光源部66が発した光L1の透過を抑制する光透過抑制部80が設けられている。
A light transmission suppression section 80 that suppresses the transmission of light L1 emitted by the light source section 66 is provided on the outer peripheral surface of each of the walls of the blood flow blocking section 20, the needle hub 40, the catheter hub 30, and the catheter shaft 28.
このような構成によれば、光源部66が発した光L1をカテーテルシャフト28の先端部35に効率よく導くことができる。
With this configuration, the light L1 emitted by the light source unit 66 can be efficiently guided to the tip 35 of the catheter shaft 28.
血管穿刺システム10は、線状部24の先端部から導出された光L1を受光する受光部84と、受光部84が受光した光L1に基づいて作成された受光画像90を表示する画像表示部86と、を備える。
The vascular puncture system 10 includes a light receiving unit 84 that receives light L1 emitted from the tip of the linear portion 24, and an image display unit 86 that displays a received light image 90 created based on the light L1 received by the light receiving unit 84.
このような構成によれば、画像表示部86に表示される受光画像90に基づいてカテーテルシャフト28の血管確保を知ることができる。
With this configuration, it is possible to know whether the catheter shaft 28 has secured the blood vessel based on the received light image 90 displayed on the image display unit 86.
血管穿刺デバイス12は、上述した光源ユニット22に代えて図11A及び図11Bに示す光源ユニット22aを有してもよい。図11A及び図11Bに示すように、光源ユニット22aは、ハウジング本体74に設けられたカバー部100を備える。カバー部100は、ハウジング70の先端よりも先端方向に突出している。カバー部100は、例えば、筒状に形成されている。
The vascular puncture device 12 may have a light source unit 22a shown in Figs. 11A and 11B instead of the light source unit 22 described above. As shown in Figs. 11A and 11B, the light source unit 22a includes a cover portion 100 provided on the housing main body 74. The cover portion 100 protrudes in the distal direction beyond the distal end of the housing 70. The cover portion 100 is formed, for example, in a cylindrical shape.
カバー部100は、光源部66が発した光L1が透過しないように形成されている。具体的に、カバー部100は、光源部66が発した光L1を透過しないように不透明な材料によって構成されている。ただし、カバー部100は、透明な材料によって構成すると共に表面にカーボンブラック等の光不透過材料を塗装することによって形成されてもよい。また、カバー部100は、透明な材料によって構成すると共に表面に金属膜を蒸着又はコーティングすることにより形成されてもよい。カバー部100は、ハウジング本体74に一体成形されていてもよいし、ハウジング本体74に対して別部材として構成されていてもよい。
The cover section 100 is formed so as to prevent the light L1 emitted by the light source section 66 from passing through it. Specifically, the cover section 100 is made of an opaque material so as to prevent the light L1 emitted by the light source section 66 from passing through it. However, the cover section 100 may be made of a transparent material and formed by painting the surface with a light-opaque material such as carbon black. The cover section 100 may also be made of a transparent material and formed by evaporating or coating a metal film on the surface. The cover section 100 may be integrally molded with the housing main body 74, or may be formed as a separate member from the housing main body 74.
図11Bに示すように、カバー部100は、光源ユニット22aを血液流通阻止部20に装着した状態で、支持部54のうち光路26を形成する部分を外側から覆うようにハウジング本体74に設けられている。この場合、支持部54の光路26のうち少なくともカバー部100によって覆われる部分には、光透過抑制部80が設けられていなくてもよい。カバー部100は、光源ユニット22aを血液流通阻止部20に装着した状態で、針ハブ40のうち光路26を形成する部分を外側から覆うようにハウジング本体74に設けられてもよい。
As shown in FIG. 11B, the cover portion 100 is provided on the housing main body 74 so as to cover from the outside the portion of the support portion 54 that forms the light path 26 when the light source unit 22a is attached to the blood flow blocking portion 20. In this case, the light transmission suppression portion 80 may not be provided on at least the portion of the light path 26 of the support portion 54 that is covered by the cover portion 100. The cover portion 100 may be provided on the housing main body 74 so as to cover from the outside the portion of the needle hub 40 that forms the light path 26 when the light source unit 22a is attached to the blood flow blocking portion 20.
血管穿刺デバイス12は、上述した光源ユニット22に代えて図12に示す光源ユニット22bを有してもよい。図12に示すように、光源ユニット22bは、光源部66、電力供給部68、ハウジング110、光伝送部112及び連結部114を備える。ハウジング110は、光源部66を収容する収容空間116を有する。電力供給部68はハウジング110に設けられている。
The vascular puncture device 12 may have a light source unit 22b shown in FIG. 12 instead of the light source unit 22 described above. As shown in FIG. 12, the light source unit 22b includes a light source section 66, a power supply section 68, a housing 110, a light transmission section 112, and a connecting section 114. The housing 110 has an accommodation space 116 that accommodates the light source section 66. The power supply section 68 is provided in the housing 110.
光伝送部112は、光源部66が発した光L1を伝送する。光伝送部112は、例えば、光ファイバである。光伝送部112の一端部は、ハウジング110に取り付けられている。光伝送部112の他端部には、連結部114が設けられている。連結部114は、装着部64に着脱可能な接続部118を有する。接続部118は、上述した接続部76と同様に構成されている。
The light transmission section 112 transmits the light L1 emitted by the light source section 66. The light transmission section 112 is, for example, an optical fiber. One end of the light transmission section 112 is attached to the housing 110. The other end of the light transmission section 112 is provided with a connecting section 114. The connecting section 114 has a connection section 118 that is detachable from the mounting section 64. The connection section 118 is configured in the same manner as the connection section 76 described above.
このような光源ユニット22bによれば、例えば、ハウジング110及び電力供給部68を床面等に載置した状態で針部材18及びカテーテル部材16を操作できる。これにより、カテーテルシャフト28の先端部35(線状部24の先端部)に十分な光量の光L1が導かれるように光源部66及び電力供給部68を大きくした場合であっても、針部材18を操作し難くなることを抑制できる。
With this type of light source unit 22b, for example, the needle member 18 and catheter member 16 can be operated with the housing 110 and power supply unit 68 placed on the floor or the like. This makes it possible to prevent the needle member 18 from becoming difficult to operate even if the light source unit 66 and power supply unit 68 are made larger so that a sufficient amount of light L1 is guided to the tip 35 of the catheter shaft 28 (the tip of the linear portion 24).
(第1変形例)
次に、第1変形例に係る血管穿刺デバイス12Aについて説明する。血管穿刺デバイス12Aにおいて、上述した構成と同一の構成には同一の参照符号を付して詳細な説明を省略する。なお、血管穿刺デバイス12Aにおいて、上述した血管穿刺デバイス12の構成と同一の構成については同一の作用効果を奏する。後述する第2~第5変形例に係る血管穿刺デバイス12B~12Eについても同様である。 (First Modification)
Next, the bloodvessel puncturing device 12A according to the first modified example will be described. In the blood vessel puncturing device 12A, the same components as those described above are given the same reference numerals, and detailed description will be omitted. Note that in the blood vessel puncturing device 12A, the same components as those in the blood vessel puncturing device 12 described above have the same effects. The same applies to the blood vessel puncturing devices 12B to 12E according to the second to fifth modified examples described below.
次に、第1変形例に係る血管穿刺デバイス12Aについて説明する。血管穿刺デバイス12Aにおいて、上述した構成と同一の構成には同一の参照符号を付して詳細な説明を省略する。なお、血管穿刺デバイス12Aにおいて、上述した血管穿刺デバイス12の構成と同一の構成については同一の作用効果を奏する。後述する第2~第5変形例に係る血管穿刺デバイス12B~12Eについても同様である。 (First Modification)
Next, the blood
図13に示すように、第1変形例に係る血管穿刺デバイス12Aは、カテーテル部材16、針部材18a、血液流通阻止部20a及び光源ユニット22を備える。血液流通阻止部20aは、針部材18aに対して着脱可能である。すなわち、第2係合部58は、第1係合部50に対して取り外し可能な状態で嵌合する。
As shown in FIG. 13, the blood vessel puncture device 12A according to the first modified example includes a catheter member 16, a needle member 18a, a blood flow blocking portion 20a, and a light source unit 22. The blood flow blocking portion 20a is detachable from the needle member 18a. In other words, the second engagement portion 58 is detachably fitted to the first engagement portion 50.
第1係合部50と第2係合部58との嵌合力(接続力)は、装着部64と接続部76との嵌合力(接続力)よりも大きくなるように形成されている。この場合、針ハブ40に対して光源ユニット22を基端方向に引っ張った時に、血液流通阻止部20aを針ハブ40に装着させたまま光源ユニット22を血液流通阻止部20aから取り外すことができる。
The mating force (connection force) between the first engaging portion 50 and the second engaging portion 58 is formed to be greater than the mating force (connection force) between the mounting portion 64 and the connection portion 76. In this case, when the light source unit 22 is pulled in the proximal direction relative to the needle hub 40, the light source unit 22 can be removed from the blood flow blocking portion 20a while keeping the blood flow blocking portion 20a attached to the needle hub 40.
針ハブ40及び血液流通阻止部20aの装着構造は、第1係合部50が凸部であり第2係合部58が凹部(孔部)であってもよい。また、当該装着構造は、凹凸による嵌合構造に限定されず、爪係合構造、磁石による吸着構造、面ファスナーによる係合構造、ねじによる螺合構造等であってもよい。
The attachment structure of the needle hub 40 and the blood flow blocking portion 20a may be such that the first engagement portion 50 is a convex portion and the second engagement portion 58 is a concave portion (hole portion). Furthermore, the attachment structure is not limited to a fitting structure using convex and concave portions, but may be a claw engagement structure, a magnetic attraction structure, a hook-and-loop fastener engagement structure, a screw-threaded structure, etc.
第1係合部50、第2係合部58、装着部64及び接続部76は、針ハブ40に対して血液流通阻止部20aを分離させる時に当該血液流通阻止部20aに作用させる力の方向と血液流通阻止部20aに対して光源ユニット22を分離させる時に当該光源ユニット22に作用させる力の方向とが互いに異なるように形成するのが好ましい。すなわち、例えば、第1係合部50及び第2係合部58が針体38の軸線方向に沿った嵌合構造である場合、装着部64及び接続部76はねじによる螺合構造に形成するのが好ましい。このような場合、血液流通阻止部20aを針ハブ40に装着させた状態のまま光源ユニット22を血液流通阻止部20aから簡単に取り外すことができる。
The first engaging portion 50, the second engaging portion 58, the mounting portion 64, and the connecting portion 76 are preferably formed so that the direction of the force acting on the blood flow blocking portion 20a when the blood flow blocking portion 20a is separated from the needle hub 40 is different from the direction of the force acting on the light source unit 22 when the light source unit 22 is separated from the blood flow blocking portion 20a. That is, for example, if the first engaging portion 50 and the second engaging portion 58 are of a fitting structure along the axial direction of the needle body 38, the mounting portion 64 and the connecting portion 76 are preferably formed of a screw-type screw structure. In such a case, the light source unit 22 can be easily removed from the blood flow blocking portion 20a while the blood flow blocking portion 20a is attached to the needle hub 40.
本変形例に係る血管穿刺デバイス12Aは、以下のような使い方をすることができる。例えば、図14Aに示すように、血管穿刺デバイス12Aの使用前の状態で、光源ユニット22を装着することができないフィルターキャップ400(血液流通阻止部)が針ハブ40の基端部に取り外し可能に接続されていることがある。
The blood vessel puncture device 12A according to this modified example can be used in the following manner. For example, as shown in FIG. 14A, before the blood vessel puncture device 12A is used, a filter cap 400 (blood flow blocking portion) to which the light source unit 22 cannot be attached may be removably connected to the base end of the needle hub 40.
このような場合、フィルターキャップ400を針ハブ40から取り外し、図14B及び図15Aに示すように、光源ユニット22が取り付けられた血液流通阻止部20aを針ハブ40に装着する。そして、線状部24(針体38及びカテーテルシャフト28)の先端部の血管確保後に、針部材18aをカテーテル部材16から抜去して光源ユニット22を血液流通阻止部20aから取り外す(図15B参照)。取り外した光源ユニット22は、再利用される。また、針部材18aと針ハブ40に装着された血液流通阻止部20aは、一緒に廃棄される。
In such a case, the filter cap 400 is removed from the needle hub 40, and the blood flow blocking part 20a with the light source unit 22 attached is attached to the needle hub 40 as shown in Figures 14B and 15A. Then, after securing the blood vessel at the tip of the linear part 24 (needle body 38 and catheter shaft 28), the needle member 18a is removed from the catheter member 16 and the light source unit 22 is removed from the blood flow blocking part 20a (see Figure 15B). The removed light source unit 22 is reused. The needle member 18a and the blood flow blocking part 20a attached to the needle hub 40 are discarded together.
本変形例において、血液流通阻止部20aは、針ハブ40の基端部に着脱可能である。
In this modified example, the blood flow blocking section 20a is detachable from the base end of the needle hub 40.
このような構成によれば、例えば、針ハブ40の基端部に光源ユニット22を取り付けることができないフィルターキャップ400が取り外し可能に接続されていた場合であっても、当該フィルターキャップ400を光源ユニット22が装着可能な血液流通阻止部20aに付け替えることができる。
With this configuration, even if a filter cap 400 that cannot be fitted with a light source unit 22 is removably connected to the base end of the needle hub 40, the filter cap 400 can be replaced with a blood flow blocking section 20a to which the light source unit 22 can be attached.
本変形例は、上述した構成に限定されない。血管穿刺デバイス12Aは、光源ユニット22に代えて光源ユニット22a、22bを備えてもよい。
This modified example is not limited to the configuration described above. The blood vessel puncture device 12A may be equipped with light source units 22a and 22b instead of the light source unit 22.
(第2変形例)
図16に示すように、第2変形例に係る血管穿刺デバイス12Bは、カテーテル部材16、針部材18b、血液流通阻止部20及び光源ユニット22を備える。針部材18bは、針体38a及び針ハブ40を有する。針体38aの内周面には、光源部66が発した光L1を反射するための反射部130(反射膜)がコーティングされている。なお、針体38aの内周面(内面)は、針体38aの基端から先端開口46の基端までの範囲に位置する部分と、先端開口46の基端から先端開口46の先端までの範囲に位置する部分との両方を含む。つまり、反射部130は、針体38aの内面のうち針体38aの外部から先端開口46を介して見える部分にも設けられている。 (Second Modification)
As shown in Fig. 16, the bloodvessel puncture device 12B according to the second modification includes a catheter member 16, a needle member 18b, a blood flow blocking section 20, and a light source unit 22. The needle member 18b has a needle body 38a and a needle hub 40. The inner peripheral surface of the needle body 38a is coated with a reflecting section 130 (reflective film) for reflecting the light L1 emitted by the light source section 66. The inner peripheral surface (inner surface) of the needle body 38a includes both a portion located in the range from the base end of the needle body 38a to the base end of the tip opening 46 and a portion located in the range from the base end of the tip opening 46 to the tip of the tip opening 46. In other words, the reflecting section 130 is also provided on the inner surface of the needle body 38a that is visible through the tip opening 46 from the outside of the needle body 38a.
図16に示すように、第2変形例に係る血管穿刺デバイス12Bは、カテーテル部材16、針部材18b、血液流通阻止部20及び光源ユニット22を備える。針部材18bは、針体38a及び針ハブ40を有する。針体38aの内周面には、光源部66が発した光L1を反射するための反射部130(反射膜)がコーティングされている。なお、針体38aの内周面(内面)は、針体38aの基端から先端開口46の基端までの範囲に位置する部分と、先端開口46の基端から先端開口46の先端までの範囲に位置する部分との両方を含む。つまり、反射部130は、針体38aの内面のうち針体38aの外部から先端開口46を介して見える部分にも設けられている。 (Second Modification)
As shown in Fig. 16, the blood
血管穿刺デバイス12Bでは、光源部66が発した光L1は、光導出孔78、フィルター56、血液流路60、針ハブ40の内腔52、針体38aの内腔42の順に導かれる。そして、針体38aの内腔42に導入された光L1は、針体38aの内面に設けられた反射部130を反射しながら先端方向に導かれ、針体38aの先端開口46から導出する。血管穿刺デバイス12Bにおいて、光導出孔78、フィルター56、血液流路60、針ハブ40の内腔52及び針体38aの内腔42は、光源部66が発した光L1を針体38aの先端部に導く光路134を形成する。
In the blood vessel puncture device 12B, the light L1 emitted by the light source unit 66 is guided in the order of the light guide hole 78, the filter 56, the blood flow path 60, the lumen 52 of the needle hub 40, and the lumen 42 of the needle body 38a. The light L1 introduced into the lumen 42 of the needle body 38a is guided toward the tip while reflecting off the reflector 130 provided on the inner surface of the needle body 38a, and is guided out from the tip opening 46 of the needle body 38a. In the blood vessel puncture device 12B, the light guide hole 78, the filter 56, the blood flow path 60, the lumen 52 of the needle hub 40, and the lumen 42 of the needle body 38a form an optical path 134 that guides the light L1 emitted by the light source unit 66 to the tip of the needle body 38a.
このような血管穿刺デバイス12Bでは、光源部66が指向性の高い光L1(例えば、レーザー光等)を発する場合、針体38aの先端開口46から多くの光L1を導出させることができる。なお、上述した血管穿刺デバイス12と同様に、光源部66が発した光L1は、カテーテルシャフト28の先端部35にも導かれる。つまり、本変形例において、光源部66が発した光L1は、針体38aの先端開口46とカテーテルシャフト28の先端部35とから導出される。ただし、光L1は、カテーテルシャフト28の先端部35から導出されなくてもよい。
In such a vascular puncture device 12B, when the light source unit 66 emits highly directional light L1 (e.g., laser light, etc.), a large amount of light L1 can be guided out from the tip opening 46 of the needle body 38a. As with the above-mentioned vascular puncture device 12, the light L1 emitted by the light source unit 66 is also guided to the tip 35 of the catheter shaft 28. In other words, in this modified example, the light L1 emitted by the light source unit 66 is guided out from the tip opening 46 of the needle body 38a and the tip 35 of the catheter shaft 28. However, the light L1 does not have to be guided out from the tip 35 of the catheter shaft 28.
血管穿刺デバイス12Bでは、線状部24の血管確保前の状態の受光画像90において、針体38aの先端開口46とカテーテルシャフト28の先端部35とが最も明るく(白色に)表示される(図17参照)。
In the vascular puncture device 12B, in the received light image 90 of the linear portion 24 before the blood vessel is secured, the tip opening 46 of the needle body 38a and the tip 35 of the catheter shaft 28 are displayed most brightly (white) (see Figure 17).
また、針体38aの先端開口46が血管302内に挿入されると共にカテーテルシャフト28の先端部35が血管302内に挿入されていない状態で、受光画像90において、針体38aの先端開口46が暗く表示される一方でカテーテルシャフト28の先端部35は明るく(白く)表示される(図6参照)。そして、針体38aの先端開口46とカテーテルシャフト28の先端部35とが血管302内に挿入されると、受光画像90において、カテーテルシャフト28の先端部35も暗く表示される(図8参照)。
In addition, when the tip opening 46 of the needle body 38a is inserted into the blood vessel 302 but the tip 35 of the catheter shaft 28 is not inserted into the blood vessel 302, the tip opening 46 of the needle body 38a appears dark in the received light image 90 while the tip 35 of the catheter shaft 28 appears bright (white) (see FIG. 6). Then, when the tip opening 46 of the needle body 38a and the tip 35 of the catheter shaft 28 are inserted into the blood vessel 302, the tip 35 of the catheter shaft 28 also appears dark in the received light image 90 (see FIG. 8).
本変形例において、光源部66が発した光L1は、針体38aの内腔42を介して当該針体38aの先端開口46から導出される。
In this modified example, the light L1 emitted by the light source unit 66 is guided through the inner cavity 42 of the needle body 38a and is guided out from the tip opening 46 of the needle body 38a.
このような構成によれば、光源部66が発した光L1に基づいて針体38aの血管確保を簡単且つ速やかに知ることができる。
With this configuration, it is possible to easily and quickly determine whether the needle body 38a has secured a blood vessel based on the light L1 emitted by the light source unit 66.
針体38aの内面には、光源部66が発した光L1が反射する反射部130が設けられている。
The inner surface of the needle body 38a is provided with a reflecting portion 130 that reflects the light L1 emitted by the light source portion 66.
このような構成によれば、光源部66が発した光L1を針体38aの先端開口46に効率よく導くことができる。
With this configuration, the light L1 emitted by the light source unit 66 can be efficiently guided to the tip opening 46 of the needle body 38a.
本変形例に係る血管穿刺デバイス12Bは、血液流通阻止部20に変えて、図18に示す血液流通阻止部20bを有してもよい。血液流通阻止部20bは、支持部140と、フィルター142とを備える。支持部140は、複数の血液流路144を有する。これら血液流路144は、支持部140の外周部に位置している。換言すれば、支持部140の中央部146は、壁部によって閉じられている。支持部140の中央部146は、光源部66が発した光L1が透過可能なように透明性を有する。
The blood vessel puncture device 12B according to this modified example may have a blood flow blocking section 20b shown in FIG. 18 instead of the blood flow blocking section 20. The blood flow blocking section 20b includes a support section 140 and a filter 142. The support section 140 has a plurality of blood flow paths 144. These blood flow paths 144 are located on the outer periphery of the support section 140. In other words, the central section 146 of the support section 140 is closed by a wall section. The central section 146 of the support section 140 is transparent so that the light L1 emitted by the light source section 66 can pass through.
各血液流路144は、支持部140の先端面(第2係合部58の先端面)から支持部140の基端面まで延在している。複数の血液流路144は、支持部140の周方向に間隔を空けて配置されている。フィルター142は、複数の血液流路144の基端開口を覆うように支持部140の基端面に固着されている。フィルター142は、環状(例えば、円環状)に延在している。針ハブ40の内腔52と複数の血液流路144とは、フラッシュバック確認用の血液流入部148を形成する。
Each blood flow path 144 extends from the distal end surface of the support part 140 (the distal end surface of the second engagement part 58) to the proximal end surface of the support part 140. The multiple blood flow paths 144 are arranged at intervals in the circumferential direction of the support part 140. The filter 142 is fixed to the proximal end surface of the support part 140 so as to cover the proximal end openings of the multiple blood flow paths 144. The filter 142 extends in an annular shape (e.g., annular). The lumen 52 of the needle hub 40 and the multiple blood flow paths 144 form a blood inlet portion 148 for checking flashback.
このような血液流通阻止部20bでは、光源部66が発した光L1は、支持部140の中央部146を通り(フィルター142を通過することなく)針ハブ40の内腔52に導かれる。この場合、フィルター142は、光L1を透過する材料に限定されないため、フィルター142の材料選定が容易となる。
In this type of blood flow blocking section 20b, the light L1 emitted by the light source section 66 passes through the center section 146 of the support section 140 (without passing through the filter 142) and is guided to the lumen 52 of the needle hub 40. In this case, the filter 142 is not limited to materials that transmit the light L1, making it easy to select the material for the filter 142.
本変形例は、上述した構成に限定されない。血管穿刺デバイス12Bは、光源ユニット22に代えて光源ユニット22a、22bを備えてもよい。血管穿刺デバイス12Bにおいて、血液流通阻止部20は、針ハブ40の基端部に着脱可能であってもよい。
This modified example is not limited to the above-mentioned configuration. The blood vessel puncture device 12B may be equipped with light source units 22a and 22b instead of the light source unit 22. In the blood vessel puncture device 12B, the blood flow blocking unit 20 may be detachable from the base end of the needle hub 40.
(第3変形例)
図19に示すように、第3変形例に係る血管穿刺デバイス12Cは、カテーテル部材16、針部材18c、血液流通阻止部20c、光源ユニット22及び導光部材150を備える。針部材18cは、針体38と針ハブ40aとを備える。 (Third Modification)
19, a bloodvessel puncture device 12C according to the third modification includes a catheter member 16, a needle member 18c, a blood flow blocking portion 20c, a light source unit 22, and a light guiding member 150. The needle member 18c includes a needle body 38 and a needle hub 40a.
図19に示すように、第3変形例に係る血管穿刺デバイス12Cは、カテーテル部材16、針部材18c、血液流通阻止部20c、光源ユニット22及び導光部材150を備える。針部材18cは、針体38と針ハブ40aとを備える。 (Third Modification)
19, a blood
針ハブ40aは、針接続孔48、内腔52、フラッシュバック確認用の血液流入部152、第1係合部50及びフィルター154を有する。針ハブ40aの内周面には、導光部材150を針体38の内腔42に導くための案内面132が設けられている。案内面132は、針体38(先端方向)に向かってテーパー状に縮径している。針体38の基端は、針接続孔48の基端よりも先端方向に位置する。針ハブ40aの内腔52は、針接続孔48の基端に連通している。血液流入部152は、針接続孔48の内周面に開口する第1開口部156と、針ハブ40aの基端面に開口する第2開口部158とを含む。
The needle hub 40a has a needle connection hole 48, a lumen 52, a blood inlet 152 for checking flashback, a first engagement portion 50, and a filter 154. The inner peripheral surface of the needle hub 40a is provided with a guide surface 132 for guiding the light guide member 150 to the lumen 42 of the needle body 38. The guide surface 132 tapers toward the needle body 38 (tip direction). The base end of the needle body 38 is located further distally than the base end of the needle connection hole 48. The lumen 52 of the needle hub 40a is connected to the base end of the needle connection hole 48. The blood inlet 152 includes a first opening 156 that opens into the inner peripheral surface of the needle connection hole 48 and a second opening 158 that opens into the base end surface of the needle hub 40a.
第1開口部156は、針体38の基端よりも基端方向に位置している。第2開口部158は、針ハブ40aの基端面に固着されたフィルター154によって覆われている。フィルター154は、空気の流通を許可する一方で血液の流通を阻止する。
The first opening 156 is located in the proximal direction from the proximal end of the needle body 38. The second opening 158 is covered by a filter 154 that is fixed to the proximal surface of the needle hub 40a. The filter 154 allows air to pass through while preventing blood from passing through.
血液流通阻止部20cは、支持部160を備える。支持部160は、第2係合部58、装着部64及び挿入孔162を有する。第2係合部58は、第1係合部50に液密及び気密に嵌合する。挿入孔162には、導光部材150が挿入される。挿入孔162は、支持部160の先端面(第2係合部58の先端面)から装着部64まで延在している。挿入孔162は、針体38の軸線の延長線上に位置する。血液流通阻止部20cは、針ハブ40aの基端部に着脱可能である。
The blood flow blocking portion 20c includes a support portion 160. The support portion 160 has a second engagement portion 58, an attachment portion 64, and an insertion hole 162. The second engagement portion 58 fits into the first engagement portion 50 in a liquid-tight and air-tight manner. The light guide member 150 is inserted into the insertion hole 162. The insertion hole 162 extends from the tip surface of the support portion 160 (the tip surface of the second engagement portion 58) to the attachment portion 64. The insertion hole 162 is located on an extension of the axis of the needle body 38. The blood flow blocking portion 20c is detachable from the base end portion of the needle hub 40a.
導光部材150は、針体38の軸線方向に沿って線状に延在している。導光部材150は、針体38の軸線上に位置する。導光部材150は、針体38の内腔42に挿入されている。導光部材150の先端は、針体38の先端開口46の近傍に位置する。
The light-guiding member 150 extends linearly along the axial direction of the needle body 38. The light-guiding member 150 is located on the axis of the needle body 38. The light-guiding member 150 is inserted into the inner cavity 42 of the needle body 38. The tip of the light-guiding member 150 is located near the tip opening 46 of the needle body 38.
導光部材150の先端面は、針体38の先端開口46を向いている。導光部材150の外径は、針体38の内径よりも小さい。すなわち、導光部材150の外周面と針体38の内周面との間には、血液を基端方向に導くための流路168が形成されている。流路168は、導光部材150の先端から針体38の基端まで延在している。
The tip surface of the light-guiding member 150 faces the tip opening 46 of the needle body 38. The outer diameter of the light-guiding member 150 is smaller than the inner diameter of the needle body 38. In other words, a flow path 168 for guiding blood in the base end direction is formed between the outer peripheral surface of the light-guiding member 150 and the inner peripheral surface of the needle body 38. The flow path 168 extends from the tip of the light-guiding member 150 to the base end of the needle body 38.
導光部材150の基端部は、支持部160に支持されている。導光部材150の基端部は、挿入孔162に挿入された状態で支持部160に対して固着されている。ただし、導光部材150は、支持部160から取り外し可能であってもよい。
The base end of the light-guiding member 150 is supported by the support portion 160. The base end of the light-guiding member 150 is fixed to the support portion 160 while being inserted into the insertion hole 162. However, the light-guiding member 150 may be removable from the support portion 160.
導光部材150の基端面は、装着部64に光源ユニット22が装着された状態で、光導出孔78を向いている。導光部材150は、針体38の先端部から血液流通阻止部20cまで連続して設けられている。導光部材150は、針体38の先端部から血液流通阻止部20cまで断続して設けられてもよい。導光部材150は、中実に形成されている。導光部材150としては、例えば、光ファイバ、アクリル棒、ガラス棒、発光チューブ等が挙げられる。
The base end surface of the light guide member 150 faces the light guide hole 78 when the light source unit 22 is attached to the attachment portion 64. The light guide member 150 is provided continuously from the tip of the needle body 38 to the blood flow blocking portion 20c. The light guide member 150 may be provided discontinuously from the tip of the needle body 38 to the blood flow blocking portion 20c. The light guide member 150 is formed solid. Examples of the light guide member 150 include an optical fiber, an acrylic rod, a glass rod, and a light emitting tube.
血液流入部152の第1開口部156の面積は、針接続孔48のうち第1開口部156よりも基端方向において導光部材150の外周面と針接続孔48の内周面との間に形成される環状の流路の横断面積よりも大きい。そのため、針体38の内腔42から針接続孔48に導出された血液は、血液流入部152に優先的に流れる。すなわち、血液が針ハブ40aの内腔52に流れることを効果的に抑えることができる。
The area of the first opening 156 of the blood inlet 152 is larger than the cross-sectional area of the annular flow path formed between the outer peripheral surface of the light-guiding member 150 and the inner peripheral surface of the needle connection hole 48 in the proximal direction from the first opening 156 of the needle connection hole 48. Therefore, blood guided from the inner cavity 42 of the needle body 38 to the needle connection hole 48 flows preferentially into the blood inlet 152. In other words, blood can be effectively prevented from flowing into the inner cavity 52 of the needle hub 40a.
血管穿刺デバイス12Cでは、上述したフィルターキャップ400(図14A参照)を針ハブ40aの基端部から取り外して、導光部材150が取り付けられている血液流通阻止部20cを針ハブ40aの基端部に装着する。この時、導光部材150は、血液流通阻止部20cを針ハブ40aに装着する時に、案内面132に案内されながら針体38の内腔42に挿入される。なお、血管穿刺デバイス12Cでは、導光部材150を単体で針体38の内腔42に挿入した後で、当該導光部材150を血液流通阻止部20cに接着(装着)してもよい。
In the blood vessel puncture device 12C, the above-mentioned filter cap 400 (see FIG. 14A) is removed from the base end of the needle hub 40a, and the blood flow blocking portion 20c to which the light guiding member 150 is attached is attached to the base end of the needle hub 40a. At this time, when the blood flow blocking portion 20c is attached to the needle hub 40a, the light guiding member 150 is inserted into the inner cavity 42 of the needle body 38 while being guided by the guide surface 132. Note that in the blood vessel puncture device 12C, the light guiding member 150 may be inserted alone into the inner cavity 42 of the needle body 38, and then the light guiding member 150 may be bonded (attached) to the blood flow blocking portion 20c.
血管穿刺デバイス12Cでは、光源部66が発した光L1は、光導出孔78、導光部材150を介して針体38の先端開口46に導かれる。血管穿刺デバイス12Cにおいて、光導出孔78及び導光部材150は、光源部66が発した光L1を針体38の先端部に導く光路170を形成する。
In the blood vessel puncture device 12C, the light L1 emitted by the light source unit 66 is guided to the tip opening 46 of the needle body 38 via the light guide hole 78 and the light guide member 150. In the blood vessel puncture device 12C, the light guide hole 78 and the light guide member 150 form a light path 170 that guides the light L1 emitted by the light source unit 66 to the tip of the needle body 38.
このような血管穿刺デバイス12Cでは、光源部66が指向性の高い光L1(例えば、レーザー光等)を発する場合、針体38の先端開口46から多くの光L1を導出させることができる。なお、上述した血管穿刺デバイス12と同様に、光源部66が発した光L1は、カテーテルシャフト28の先端部35にも導かれる。つまり、本変形例において、光源部66が発した光L1は、針体38の先端開口46とカテーテルシャフト28の先端部35とから導出される。ただし、光L1は、カテーテルシャフト28の先端部35から導出されなくてもよい。
In such a vascular puncture device 12C, when the light source unit 66 emits highly directional light L1 (e.g., laser light, etc.), a large amount of light L1 can be guided out from the tip opening 46 of the needle body 38. As with the above-mentioned vascular puncture device 12, the light L1 emitted by the light source unit 66 is also guided to the tip 35 of the catheter shaft 28. In other words, in this modified example, the light L1 emitted by the light source unit 66 is guided out from the tip opening 46 of the needle body 38 and the tip 35 of the catheter shaft 28. However, the light L1 does not have to be guided out from the tip 35 of the catheter shaft 28.
血管穿刺デバイス12Cにおいて、受光画像90の見え方は、第2変形例に係る血管穿刺デバイス12Bと同様であるため、その説明を省略する。
In the blood vessel puncture device 12C, the appearance of the received light image 90 is similar to that of the blood vessel puncture device 12B of the second modified example, so a description thereof will be omitted.
光路170は、光源ユニット22の光L1を針体38の先端部に導くための導光部材150を含む。
The optical path 170 includes a light-guiding member 150 for guiding the light L1 from the light source unit 22 to the tip of the needle body 38.
このような構成によれば、光源部66が発した光L1を針体38の先端開口46から導出させることができる。
With this configuration, the light L1 emitted by the light source unit 66 can be guided out from the tip opening 46 of the needle body 38.
導光部材150の先端部は、針体38の内腔42に挿入された状態で当該針体38の先端部に位置する。
The tip of the light-guiding member 150 is positioned at the tip of the needle body 38 when inserted into the inner cavity 42 of the needle body 38.
このような構成によれば、光源部66が発した光L1を針体38の先端開口46に効率よく導くことができる。
With this configuration, the light L1 emitted by the light source unit 66 can be efficiently guided to the tip opening 46 of the needle body 38.
導光部材150の基端部は、血液流通阻止部20cに支持されている。
The base end of the light-guiding member 150 is supported by the blood flow blocking section 20c.
このような構成によれば、血液流通阻止部20cに対する導光部材150の基端部の位置ずれが抑制されるため、光源部66が発した光L1を導光部材150に効率よく導入できる。
This configuration prevents the base end of the light-guiding member 150 from shifting relative to the blood flow blocking portion 20c, so that the light L1 emitted by the light source 66 can be efficiently guided to the light-guiding member 150.
血液流通阻止部20cは、針ハブ40aの基端部に着脱可能である。針ハブ40aの内面には、血液流通阻止部20cを針ハブ40aの基端部に装着する時に導光部材150を針体38の内腔42に導くための案内面132が設けられている。案内面132は、針体38に向かってテーパー状に縮径している。
The blood flow blocking portion 20c is detachable from the base end of the needle hub 40a. The inner surface of the needle hub 40a is provided with a guide surface 132 for guiding the light guide member 150 into the inner cavity 42 of the needle body 38 when the blood flow blocking portion 20c is attached to the base end of the needle hub 40a. The guide surface 132 tapers toward the needle body 38.
このような構成によれば、血液流通阻止部20cを針ハブ40aの基端部に装着する時に、案内面132によって導光部材150を針体38の内腔42に円滑に挿入できる。
With this configuration, when the blood flow blocking portion 20c is attached to the base end of the needle hub 40a, the guide surface 132 allows the light guide member 150 to be smoothly inserted into the inner cavity 42 of the needle body 38.
本変形例は、上述した構成に限定されない。血管穿刺デバイス12Cは、光源ユニット22に代えて光源ユニット22a、22bを備えてもよい。血管穿刺デバイス12Cにおいて、血液流通阻止部20cは、針ハブ40aの基端部に固定されていてもよい。
This modified example is not limited to the above-mentioned configuration. The blood vessel puncture device 12C may be equipped with light source units 22a and 22b instead of the light source unit 22. In the blood vessel puncture device 12C, the blood flow blocking portion 20c may be fixed to the base end of the needle hub 40a.
(第4変形例)
図20に示すように、第4変形例に係る血管穿刺デバイス12Dは、カテーテル部材16、針部材18d、血液流通阻止部20d、光源ユニット22及び導光部材150aを備える。血液流通阻止部20dは、支持部180とフィルター56とを備える。 (Fourth Modification)
20, a blood vessel puncture device 12D according to the fourth modification includes acatheter member 16, a needle member 18d, a blood flow blocking unit 20d, a light source unit 22, and a light guiding member 150a. The blood flow blocking unit 20d includes a support member 180 and a filter 56.
図20に示すように、第4変形例に係る血管穿刺デバイス12Dは、カテーテル部材16、針部材18d、血液流通阻止部20d、光源ユニット22及び導光部材150aを備える。血液流通阻止部20dは、支持部180とフィルター56とを備える。 (Fourth Modification)
20, a blood vessel puncture device 12D according to the fourth modification includes a
針部材18dは、針体38及び針ハブ40bを有する。針ハブ40bの内周面には、上述した案内面132が設けられている。
Needle member 18d has a needle body 38 and a needle hub 40b. The inner peripheral surface of needle hub 40b is provided with the above-mentioned guide surface 132.
支持部180は、第2係合部58、装着部64、挿入孔182及びフラッシュバック確認用の血液流入部184を有する。挿入孔182には、導光部材150aが挿入される。挿入孔182は、支持部180の先端面(第2係合部58の先端面)に開口している。すなわち、挿入孔182は、針ハブ40bの内腔52に連通している。血液流入部184は、挿入孔182の基端に連通している。フィルター56は、血液流入部184内の血液の装着部64への流通を阻止するように支持部180に支持されている。
The support part 180 has a second engagement part 58, an attachment part 64, an insertion hole 182, and a blood inlet part 184 for checking flashback. The light guide member 150a is inserted into the insertion hole 182. The insertion hole 182 opens to the distal end surface of the support part 180 (the distal end surface of the second engagement part 58). In other words, the insertion hole 182 is connected to the inner cavity 52 of the needle hub 40b. The blood inlet part 184 is connected to the base end of the insertion hole 182. The filter 56 is supported by the support part 180 so as to prevent blood in the blood inlet part 184 from flowing to the attachment part 64.
導光部材150aは、管状に形成されている。導光部材150aは、アクリル、ガラス、発光チューブ等によって形成されている。導光部材150aは、針体38の軸線方向に沿って線状に延在している。導光部材150aは、針体38の軸線上に位置する。導光部材150aは、針体38の内腔42に挿入されている。導光部材150aの先端は、針体38の先端開口46の近傍に位置する。導光部材150aの先端面は、針体38の先端開口46を向いている。導光部材150aの外周面は、針体38の内周面に液密に密着している。ただし、導光部材150aの外周面は、針体38の内周面から離間していてもよい。
The light-guiding member 150a is formed in a tubular shape. The light-guiding member 150a is made of acrylic, glass, a light-emitting tube, or the like. The light-guiding member 150a extends linearly along the axial direction of the needle body 38. The light-guiding member 150a is located on the axis of the needle body 38. The light-guiding member 150a is inserted into the inner cavity 42 of the needle body 38. The tip of the light-guiding member 150a is located near the tip opening 46 of the needle body 38. The tip surface of the light-guiding member 150a faces the tip opening 46 of the needle body 38. The outer peripheral surface of the light-guiding member 150a is in liquid-tight contact with the inner peripheral surface of the needle body 38. However, the outer peripheral surface of the light-guiding member 150a may be spaced from the inner peripheral surface of the needle body 38.
導光部材150aの基端部は、支持部180に支持されている。導光部材150aの基端部は、挿入孔182に挿入された状態で支持部180に対して固着されている。ただし、導光部材150aは、支持部180から取り外し可能であってもよい。導光部材150aの基端面は、光源部66の光軸上に位置する。導光部材150aの内腔151の基端は、血液流入部184に連通している。
The base end of the light-guiding member 150a is supported by the support portion 180. The base end of the light-guiding member 150a is fixed to the support portion 180 while inserted into the insertion hole 182. However, the light-guiding member 150a may be removable from the support portion 180. The base end surface of the light-guiding member 150a is located on the optical axis of the light source portion 66. The base end of the inner cavity 151 of the light-guiding member 150a is connected to the blood inlet portion 184.
血管穿刺デバイス12Dでは、上述したフィルターキャップ400(図14A参照)を針ハブ40bの基端部から取り外して、導光部材150aが取り付けられている血液流通阻止部20dを針ハブ40bの基端部に装着する。この時、導光部材150aは、案内面132に案内されながら針体38の内腔42に挿入される。なお、血管穿刺デバイス12Dでは、導光部材150aを単体で針体38の内腔42に挿入した後で、当該導光部材150aを血液流通阻止部20dに接着(装着)してもよい。
In the blood vessel puncture device 12D, the above-mentioned filter cap 400 (see FIG. 14A) is removed from the base end of the needle hub 40b, and the blood flow blocking section 20d to which the light guiding member 150a is attached is attached to the base end of the needle hub 40b. At this time, the light guiding member 150a is inserted into the lumen 42 of the needle body 38 while being guided by the guide surface 132. Note that in the blood vessel puncture device 12D, the light guiding member 150a may be inserted alone into the lumen 42 of the needle body 38, and then the light guiding member 150a may be adhered (attached) to the blood flow blocking section 20d.
血管穿刺デバイス12Dでは、光源部66が発した光L1は、光導出孔78、フィルター56、血液流入部184、導光部材150aを介して針体38の先端開口46に導かれる。血管穿刺デバイス12Dにおいて、光導出孔78、フィルター56、血液流入部184及び導光部材150aは、光源部66が発した光L1を針体38の先端部に導く光路186を形成する。
In the blood vessel puncture device 12D, the light L1 emitted by the light source unit 66 is guided to the tip opening 46 of the needle body 38 via the light guide hole 78, the filter 56, the blood inlet section 184, and the light guide member 150a. In the blood vessel puncture device 12D, the light guide hole 78, the filter 56, the blood inlet section 184, and the light guide member 150a form an optical path 186 that guides the light L1 emitted by the light source unit 66 to the tip of the needle body 38.
このような血管穿刺デバイス12Dでは、光源部66が指向性の高い光L1(例えば、レーザー光等)を発する場合、針体38の先端開口46から多くの光L1を導出させることができる。なお、上述した血管穿刺デバイス12と同様に、光源部66が発した光L1は、カテーテルシャフト28の先端部35にも導かれる。つまり、本変形例において、光源部66が発した光L1は、針体38の先端開口46とカテーテルシャフト28の先端部35とから導出される。ただし、光L1は、カテーテルシャフト28の先端部35から導出されなくてもよい。
In such a vascular puncture device 12D, when the light source unit 66 emits highly directional light L1 (e.g., laser light, etc.), a large amount of light L1 can be guided out from the tip opening 46 of the needle body 38. As with the above-mentioned vascular puncture device 12, the light L1 emitted by the light source unit 66 is also guided to the tip 35 of the catheter shaft 28. In other words, in this modified example, the light L1 emitted by the light source unit 66 is guided out from the tip opening 46 of the needle body 38 and the tip 35 of the catheter shaft 28. However, the light L1 does not have to be guided out from the tip 35 of the catheter shaft 28.
血管穿刺デバイス12Dにおいて、受光画像90の見え方は、第2変形例に係る血管穿刺デバイス12Bと同様であるため、その説明を省略する。本変形例に係る血管穿刺デバイス12Dにおいて、上述した血管穿刺デバイス12Cと同様の構成については同様の効果を奏する。
In the blood vessel puncture device 12D, the appearance of the received light image 90 is similar to that of the blood vessel puncture device 12B of the second modified example, and therefore a description thereof will be omitted. In the blood vessel puncture device 12D of this modified example, the same configuration as the blood vessel puncture device 12C described above provides the same effects.
本変形例は、上述した構成に限定されない。血管穿刺デバイス12Dは、光源ユニット22に代えて光源ユニット22a、22bを備えてもよい。血管穿刺デバイス12Dにおいて、血液流通阻止部20dは、針ハブ40bの基端部に固定されていてもよい。
This modified example is not limited to the above-mentioned configuration. The blood vessel puncture device 12D may be equipped with light source units 22a and 22b instead of the light source unit 22. In the blood vessel puncture device 12D, the blood flow blocking portion 20d may be fixed to the base end of the needle hub 40b.
(第5変形例)
図21に示すように、第5変形例に係る血管穿刺デバイス12Eは、カテーテル部材16、針部材18e、血液流通阻止部20e、光源ユニット22及び導光部材150を備える。針部材18eは、針体38と針ハブ40cとを備える。血液流通阻止部20eは、針ハブ40cの基端部に対して液密に装着された状態で針体38の軸線方向に沿って移動可能である。 (Fifth Modification)
21 , a bloodvessel puncture device 12E according to the fifth modification includes a catheter member 16, a needle member 18e, a blood flow blocking portion 20e, a light source unit 22, and a light guiding member 150. The needle member 18e includes a needle body 38 and a needle hub 40c. The blood flow blocking portion 20e is liquid-tightly attached to the base end of the needle hub 40c and is movable along the axial direction of the needle body 38.
図21に示すように、第5変形例に係る血管穿刺デバイス12Eは、カテーテル部材16、針部材18e、血液流通阻止部20e、光源ユニット22及び導光部材150を備える。針部材18eは、針体38と針ハブ40cとを備える。血液流通阻止部20eは、針ハブ40cの基端部に対して液密に装着された状態で針体38の軸線方向に沿って移動可能である。 (Fifth Modification)
21 , a blood
針ハブ40cの基端部(第1係合部50)には、雌ねじ部41が設けられている。針ハブ40cの雌ねじ部41以外の構成は、上述した針ハブ40aと同様に構成されている。血液流通阻止部20eの先端部(第2係合部58)には、雌ねじ部41に螺合する雄ねじ部21が設けられている。血液流通阻止部20eの雄ねじ部21以外の構成は、上述した血液流通阻止部20cと同様に構成されている。
The base end (first engagement portion 50) of the needle hub 40c is provided with a female thread portion 41. The configuration of the needle hub 40c other than the female thread portion 41 is the same as that of the needle hub 40a described above. The tip end (second engagement portion 58) of the blood flow blocking portion 20e is provided with a male thread portion 21 that screws into the female thread portion 41. The configuration of the blood flow blocking portion 20e other than the male thread portion 21 is the same as that of the blood flow blocking portion 20c described above.
血管穿刺デバイス12Eでは、血液流通阻止部20eを針ハブ40cに対して回転させることにより、針体38の先端開口46に対する導光部材150の先端位置を針体38の軸線方向に変位させることができる。すなわち、雄ねじ部21及び雌ねじ部41は、針体38の軸線方向における先端開口46に対する導光部材150の先端位置を調整するための位置調整機構として機能する。雄ねじ部21は、雌ねじ部41に対して液密に接触する。つまり、雄ねじ部21及び雌ねじ部41は、針ハブ40cと血液流通阻止部20eとの間からの血液の漏出を防止する機能も有する。
In the blood vessel puncture device 12E, the tip position of the light-guiding member 150 relative to the tip opening 46 of the needle body 38 can be displaced in the axial direction of the needle body 38 by rotating the blood flow blocking portion 20e relative to the needle hub 40c. That is, the male thread portion 21 and the female thread portion 41 function as a position adjustment mechanism for adjusting the tip position of the light-guiding member 150 relative to the tip opening 46 in the axial direction of the needle body 38. The male thread portion 21 is in liquid-tight contact with the female thread portion 41. That is, the male thread portion 21 and the female thread portion 41 also have the function of preventing blood from leaking between the needle hub 40c and the blood flow blocking portion 20e.
血管穿刺デバイス12Eにおいて、導光部材150は、先端開口46から突出している。詳細には、導光部材150の先端は、針体38の先端と先端開口46の基端との間に位置する。これにより、針体38の穿刺抵抗を抑えつつ針体38の先端部を効率よく発光させることができる。
In the vascular puncture device 12E, the light-guiding member 150 protrudes from the tip opening 46. In particular, the tip of the light-guiding member 150 is located between the tip of the needle body 38 and the base end of the tip opening 46. This allows the tip of the needle body 38 to emit light efficiently while suppressing the puncture resistance of the needle body 38.
導光部材150の先端位置は、血管穿刺デバイス12Eの製造公差(組立公差、導光部材150の長さのばらつき等)によって、適切な位置(図21の位置)からずれることがある。導光部材150の先端が針体38の先端よりも先端方向に位置すると、穿刺抵抗が大きくなる。また、導光部材150の先端が先端開口46の基端よりも基端方向に位置すると、先端開口46から導出される光量が少なくなる。導光部材150の先端の適切な位置に対する製造公差によるずれ量は、1mm以下である。つまり、本変形例では、導光部材150の先端位置の調整代が1mm程度あれば、導光部材150の先端を適切な位置に調整し得る。この場合、導光部材150の先端位置を調整するために針ハブ40cに対して血液流通阻止部20eを回転させても雄ねじ部21と雌ねじ部41とは液密に接触した状態を維持する。つまり、血液が雄ねじ部21と雌ねじ部41との間から漏れることを抑制できる。
The tip position of the light-guiding member 150 may deviate from the appropriate position (position in FIG. 21) due to manufacturing tolerances of the blood vessel puncture device 12E (assembly tolerances, variation in the length of the light-guiding member 150, etc.). If the tip of the light-guiding member 150 is located more distally than the tip of the needle body 38, the puncture resistance increases. Also, if the tip of the light-guiding member 150 is located more proximally than the proximally of the tip opening 46, the amount of light guided from the tip opening 46 decreases. The deviation from the appropriate position of the tip of the light-guiding member 150 due to manufacturing tolerances is 1 mm or less. In other words, in this modified example, if the adjustment margin for the tip position of the light-guiding member 150 is about 1 mm, the tip of the light-guiding member 150 can be adjusted to the appropriate position. In this case, even if the blood flow blocking portion 20e is rotated relative to the needle hub 40c to adjust the tip position of the light-guiding member 150, the male thread portion 21 and the female thread portion 41 maintain a liquid-tight contact state. In other words, blood leakage between the male thread portion 21 and the female thread portion 41 can be prevented.
血管穿刺デバイス12Eは、導光部材150の先端位置を調整した後で、針ハブ40cに対する血液流通阻止部20eの回転を阻止するロック機構を備えてもよい。この場合、血管穿刺デバイス12Eの使用時等に導光部材150の先端が適切な位置からずれることを抑制できる。第2係合部58における雄ねじ部21よりも基端側には、血液流通阻止部20eと針ハブ40cとの間からの血液の漏出を阻止する図示しないシール部材が設けられてもよい。このようなシール部材としては、例えば、環状のゴムシール等が挙げられる。
The blood vessel puncture device 12E may be provided with a locking mechanism that prevents the blood flow blocking portion 20e from rotating relative to the needle hub 40c after the tip position of the light guiding member 150 has been adjusted. In this case, it is possible to prevent the tip of the light guiding member 150 from shifting from the appropriate position when the blood vessel puncture device 12E is in use, etc. A sealing member (not shown) that prevents blood from leaking between the blood flow blocking portion 20e and the needle hub 40c may be provided on the base end side of the male thread portion 21 in the second engagement portion 58. An example of such a sealing member is an annular rubber seal.
血管穿刺デバイス12Eにおいて、血液流通阻止部20eは、針ハブ40cの基端部に対して液密に装着された状態で針体38の軸線方向に沿って移動可能である。このような構成によれば、血管穿刺デバイス12Eの製造公差によって導光部材150の先端位置が適切な位置からずれた場合であっても、血液流通阻止部20eを針ハブ40cに対して針体38の軸線方向に移動させることにより、導光部材150の先端を適切な位置に簡単に調節できる。
In the blood vessel puncture device 12E, the blood flow blocking portion 20e is liquid-tightly attached to the base end of the needle hub 40c and can move along the axial direction of the needle body 38. With this configuration, even if the tip position of the light-guiding member 150 deviates from the appropriate position due to manufacturing tolerances in the blood vessel puncture device 12E, the tip of the light-guiding member 150 can be easily adjusted to the appropriate position by moving the blood flow blocking portion 20e in the axial direction of the needle body 38 relative to the needle hub 40c.
また、針ハブ40cの基端部には、雌ねじ部41が設けられ、血液流通阻止部20eの先端部には、雌ねじ部41に螺合する雄ねじ部21が設けられている。このような構成によれば、針ハブ40cに対して血液流通阻止部20eを回転させることにより導光部材150の先端位置を簡単に調節できる。
Furthermore, a female thread portion 41 is provided at the base end of the needle hub 40c, and a male thread portion 21 that screws into the female thread portion 41 is provided at the tip end of the blood flow blocking portion 20e. With this configuration, the tip position of the light guide member 150 can be easily adjusted by rotating the blood flow blocking portion 20e relative to the needle hub 40c.
さらに、雄ねじ部21は、雌ねじ部41に対して液密に接触する。このような構成によれば、針ハブ40cと血液流通阻止部20eとの間からの血液の漏出を防止するためのシール部材等を設けなくもよいため、血管穿刺デバイス12Eの構成を簡単にできる。また、シール部材によって針ハブ40cに対する血液流通阻止部20eの回転抵抗が増大することがないため、導光部材150の先端位置の調整を簡単に行い得る。
Furthermore, the male thread portion 21 is in liquid-tight contact with the female thread portion 41. With this configuration, it is not necessary to provide a seal member or the like to prevent blood from leaking between the needle hub 40c and the blood flow blocking portion 20e, simplifying the configuration of the blood vessel puncture device 12E. In addition, the seal member does not increase the rotational resistance of the blood flow blocking portion 20e relative to the needle hub 40c, making it easy to adjust the tip position of the light-guiding member 150.
なお、本発明は、上述した開示に限らず、本発明の要旨を逸脱することなく、種々の構成を採り得る。
The present invention is not limited to the above disclosure, and various configurations may be adopted without departing from the gist of the present invention.
Claims (20)
- 生体部位の血管に穿刺可能な線状部を備え、当該線状部は管状の針体を含み、前記針体の基端部には針ハブが設けられた血管穿刺デバイスであって、
前記針ハブの基端部に設けられた血液流通阻止部と、
光を発する光源部を有し、且つ前記血液流通阻止部の装着部に着脱可能である光源ユニットと、
前記光源部が発した前記光を前記線状部の先端部に導く光路と、を備え、
前記光源部が発した前記光は、前記線状部の前記先端部から外部に導出され、
前記針ハブ及び前記血液流通阻止部の少なくともいずれかには、前記針体の先端開口から流入した血液が導かれるフラッシュバック確認用の血液流入部が設けられ、
前記血液流通阻止部は、前記血液の前記装着部への流通が阻止されるように形成されている、血管穿刺デバイス。 A blood vessel puncture device comprising a linear portion capable of puncturing a blood vessel at a living body site, the linear portion including a tubular needle body, and a needle hub provided at a base end of the needle body,
a blood flow blocking portion provided at a proximal end of the needle hub;
a light source unit having a light source section that emits light and that is detachable from the attachment section of the blood flow blocking section;
an optical path for guiding the light emitted by the light source unit to a tip end of the linear portion,
The light emitted by the light source unit is guided to the outside from the tip end of the linear portion,
At least one of the needle hub and the blood flow blocking portion is provided with a blood inlet portion for checking flashback, into which blood flowing in from the tip opening of the needle body is guided;
A blood vessel puncture device, wherein the blood flow blocking portion is formed to block the flow of blood to the attachment portion. - 請求項1記載の血管穿刺デバイスであって、
前記光源ユニットが前記装着部に装着された状態で、前記光源部は、前記線状部の先端方向に向かって前記光を発する、血管穿刺デバイス。 The vascular puncture device according to claim 1,
A blood vessel puncture device, wherein when the light source unit is attached to the attachment portion, the light source portion emits the light toward the tip direction of the linear portion. - 請求項1記載の血管穿刺デバイスであって、
前記光源ユニットは、前記光源部を収容するハウジングを有し、
前記ハウジングは、前記装着部に着脱可能な接続部を有する、血管穿刺デバイス。 The vascular puncture device according to claim 1,
The light source unit has a housing that accommodates the light source portion,
A vascular puncture device, wherein the housing has a connection portion that is detachable from the mounting portion. - 請求項1記載の血管穿刺デバイスであって、
前記血液流通阻止部は、前記針ハブの前記基端部に固定されている、血管穿刺デバイス。 The vascular puncture device according to claim 1,
A blood vessel puncture device, wherein the blood flow blocking portion is fixed to the base end of the needle hub. - 請求項1記載の血管穿刺デバイスであって、
前記血液流通阻止部は、前記針ハブの前記基端部に着脱可能である、血管穿刺デバイス。 The vascular puncture device according to claim 1,
A blood vessel puncture device, wherein the blood flow blocking portion is detachable from the base end portion of the needle hub. - 請求項1記載の血管穿刺デバイスであって、
前記光源部が発した前記光は、前記針体の内腔を介して当該針体の前記先端開口から導出される、血管穿刺デバイス。 The vascular puncture device according to claim 1,
A blood vessel puncture device, wherein the light emitted by the light source unit is guided through an inner cavity of the needle body and out of the tip opening of the needle body. - 請求項6記載の血管穿刺デバイスであって、
前記針体の内面には、前記光源部が発した前記光が反射する反射部が設けられている、血管穿刺デバイス。 The vascular puncture device according to claim 6,
A blood vessel puncture device, wherein an inner surface of the needle body is provided with a reflecting portion that reflects the light emitted by the light source portion. - 請求項6記載の血管穿刺デバイスであって、
前記光路は、前記光源部が発した前記光を前記針体の先端部に導くための導光部材を含む、血管穿刺デバイス。 The vascular puncture device according to claim 6,
A blood vessel puncture device, wherein the optical path includes a light guiding member for guiding the light emitted by the light source unit to the tip of the needle body. - 請求項8記載の血管穿刺デバイスであって、
前記導光部材の先端部は、前記針体の前記内腔に挿入された状態で当該針体の前記先端部に位置する、血管穿刺デバイス。 9. The vascular puncture device according to claim 8,
A blood vessel puncture device, wherein the tip of the light guiding member is positioned at the tip of the needle body when inserted into the inner cavity of the needle body. - 請求項8記載の血管穿刺デバイスであって、
前記導光部材の基端部は、前記血液流通阻止部に支持されている、血管穿刺デバイス。 9. The vascular puncture device according to claim 8,
A blood vessel puncture device, wherein a proximal end of the light guiding member is supported by the blood flow blocking portion. - 請求項10記載の血管穿刺デバイスであって、
前記血液流通阻止部は、前記針ハブの前記基端部に着脱可能であり、
前記針ハブの内面には、前記血液流通阻止部を前記針ハブの前記基端部に装着する時に前記導光部材を前記針体の前記内腔に導くための案内面が設けられ、
前記案内面は、前記針体に向かってテーパー状に縮径している、血管穿刺デバイス。 11. The vascular puncture device of claim 10,
the blood flow blocking portion is detachable from the base end portion of the needle hub,
a guide surface is provided on an inner surface of the needle hub for guiding the light guiding member into the inner cavity of the needle body when the blood flow blocking unit is attached to the base end of the needle hub;
A blood vessel puncture device, wherein the guide surface tapers toward the needle body. - 請求項1記載の血管穿刺デバイスであって、
前記血液流通阻止部は、
前記血液流入部から前記装着部への前記血液の流通を阻止するフィルターと、
前記フィルターを支持する支持部と、を備え、
前記装着部は、前記支持部の基端部に設けられている、血管穿刺デバイス。 The vascular puncture device according to claim 1,
The blood flow blocking portion is
a filter that blocks the flow of blood from the blood inlet portion to the attachment portion;
A support portion that supports the filter,
A vascular puncture device, wherein the mounting portion is provided at a base end of the support portion. - 請求項1記載の血管穿刺デバイスであって、
前記光源部は、近赤外光を含む前記光を発する、血管穿刺デバイス。 The vascular puncture device according to claim 1,
A vascular puncture device, wherein the light source unit emits light including near-infrared light. - 請求項1記載の血管穿刺デバイスであって、
前記針体が挿通する内腔を有する管状のカテーテルシャフトと、
前記カテーテルシャフトの基端部に設けられて前記針体が挿通する内腔を有するカテーテルハブと、を備え、
前記線状部は、前記針体と前記カテーテルシャフトとを含む、血管穿刺デバイス。 The vascular puncture device according to claim 1,
a tubular catheter shaft having a lumen through which the needle body is inserted;
a catheter hub provided at a base end of the catheter shaft and having an inner cavity through which the needle body is inserted;
A vascular puncture device, wherein the linear portion includes the needle body and the catheter shaft. - 請求項14記載の血管穿刺デバイスであって、
前記光路は、前記血液流通阻止部の壁部、前記針ハブの壁部、前記カテーテルハブの壁部及び前記カテーテルシャフトの壁部に設けられ、
前記光源部が発した光は、前記カテーテルシャフトの先端部から前記外部に導出される、血管穿刺デバイス。 15. The vascular puncture device of claim 14,
the optical path is provided on a wall of the blood flow blocking portion, a wall of the needle hub, a wall of the catheter hub, and a wall of the catheter shaft;
A vascular puncture device, wherein the light emitted by the light source unit is guided to the outside from the tip of the catheter shaft. - 請求項15記載の血管穿刺デバイスであって、
前記血液流通阻止部の壁部、前記針ハブの壁部、前記カテーテルハブの壁部及び前記カテーテルシャフトの壁部の各々の外周面には、前記光源部が発した前記光の透過を抑制する光透過抑制部が設けられている、血管穿刺デバイス。 16. The vascular puncture device of claim 15,
A vascular puncture device, wherein the outer peripheral surfaces of each of the wall portions of the blood flow blocking portion, the wall portion of the needle hub, the wall portion of the catheter hub, and the wall portion of the catheter shaft are provided with a light transmission suppression portion that suppresses the transmission of the light emitted by the light source portion. - 請求項10記載の血管穿刺デバイスであって、
前記血液流通阻止部は、前記針ハブの前記基端部に対して液密に装着された状態で前記針体の軸線方向に沿って移動可能である、血管穿刺デバイス。 11. The vascular puncture device of claim 10,
A blood vessel puncture device, wherein the blood flow blocking portion is liquid-tightly attached to the base end of the needle hub and is movable along the axial direction of the needle body. - 請求項17記載の血管穿刺デバイスであって、
前記針ハブの前記基端部には、雌ねじ部が設けられ、
前記血液流通阻止部の先端部には、前記雌ねじ部に螺合する雄ねじ部が設けられている、血管穿刺デバイス。 18. The vascular puncture device of claim 17,
The proximal end of the needle hub is provided with an internal thread portion,
A blood vessel puncture device, wherein a tip portion of the blood flow blocking portion is provided with a male thread portion that screws into the female thread portion. - 請求項18記載の血管穿刺デバイスであって、
前記雄ねじ部は、前記雌ねじ部に対して液密に接触する、血管穿刺デバイス。 20. The vascular puncture device of claim 18,
A vascular puncture device, wherein the male threaded portion is in liquid-tight contact with the female threaded portion. - 請求項1~19のいずれか1項に記載の血管穿刺デバイスと、
前記線状部の前記先端部から導出された前記光を受光する受光部と、
前記受光部が受光した前記光に基づいて作成された受光画像を表示する画像表示部と、を備える、血管穿刺システム。 A vascular puncture device according to any one of claims 1 to 19,
a light receiving portion that receives the light guided from the tip portion of the linear portion;
and an image display unit that displays a received light image created based on the light received by the light receiving unit.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022153529 | 2022-09-27 | ||
JP2022-153529 | 2022-09-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024070898A1 true WO2024070898A1 (en) | 2024-04-04 |
Family
ID=90477689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2023/034346 WO2024070898A1 (en) | 2022-09-27 | 2023-09-21 | Blood vessel piercing device and blood vessel piercing system |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024070898A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010528818A (en) * | 2007-06-11 | 2010-08-26 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | Three-dimensional light guidance for catheter placement |
JP2013009949A (en) * | 2011-06-28 | 2013-01-17 | Christie Digital Systems Usa Inc | Method and apparatus for detection of catheter location for intravenous access |
US20150314105A1 (en) * | 2012-08-21 | 2015-11-05 | Optomeditech Oy | Intravascular Catheter Assembly |
WO2021059934A1 (en) * | 2019-09-25 | 2021-04-01 | テルモ株式会社 | Catheter assembly |
WO2022176880A1 (en) * | 2021-02-22 | 2022-08-25 | テルモ株式会社 | Blood vessel puncture device and blood vessel puncture system |
-
2023
- 2023-09-21 WO PCT/JP2023/034346 patent/WO2024070898A1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010528818A (en) * | 2007-06-11 | 2010-08-26 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | Three-dimensional light guidance for catheter placement |
JP2013009949A (en) * | 2011-06-28 | 2013-01-17 | Christie Digital Systems Usa Inc | Method and apparatus for detection of catheter location for intravenous access |
US20150314105A1 (en) * | 2012-08-21 | 2015-11-05 | Optomeditech Oy | Intravascular Catheter Assembly |
WO2021059934A1 (en) * | 2019-09-25 | 2021-04-01 | テルモ株式会社 | Catheter assembly |
WO2022176880A1 (en) * | 2021-02-22 | 2022-08-25 | テルモ株式会社 | Blood vessel puncture device and blood vessel puncture system |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10750934B2 (en) | Endoscopic system for optimized visualization | |
US9339337B2 (en) | Tapered liquid light guide | |
WO2022176880A1 (en) | Blood vessel puncture device and blood vessel puncture system | |
EP3685734A1 (en) | Medical device featuring cladded waveguide | |
US12023005B2 (en) | Positioning a tube in a lumen via transillumination | |
CN107811603B (en) | Hysteroscope | |
EP2268196A1 (en) | Light-guided transluminal catheter | |
EP3570723A1 (en) | Handheld surgical endoscope | |
WO2003075979A2 (en) | Chemiluminescently illuminated medical appliances | |
WO2004012589A3 (en) | Catheter for diagnosis and treatment of diseased vessels | |
US11849917B2 (en) | Disposable miniature endoscopy system | |
KR20180050648A (en) | A therapeutic substance delivery device, and a therapeutic substance delivery kit | |
WO2015157518A1 (en) | Sterilization for needleless connectors | |
US20220322924A1 (en) | A light guiding assembly for light exposure of a medical tube | |
WO2021024992A1 (en) | System for detecting position of distal end of medical tube | |
WO2024070898A1 (en) | Blood vessel piercing device and blood vessel piercing system | |
JP2016087091A (en) | Catheter device and catheter position confirmation method | |
WO2024162229A1 (en) | Blood vessel piercing device and blood vessel piercing system | |
JP5175673B2 (en) | Indwelling needle missing device and indwelling needle assembly | |
WO2023189225A1 (en) | Catheter assembly and blood vessel puncturing system | |
JP7498721B2 (en) | Catheter Assembly | |
WO2022044894A1 (en) | Catheter, catheter assembly, and catheter system | |
JP2022108001A (en) | liquid injection port | |
US10413380B2 (en) | Illuminated catheterization device | |
WO2023153321A1 (en) | Catheter assembly and catheter system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23872124 Country of ref document: EP Kind code of ref document: A1 |